About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
3170 genotypes with 6407 annotations displayed of selected term and subterms
Searched Term: abnormal glucose homeostasis
Allelic Composition
(Genetic Background)		 Annotated Term Reference
2210408I21Riktm1b(EUCOMM)Wtsi/2210408I21Riktm1b(EUCOMM)Wtsi
(C57BL/6N-2210408I21Riktm1b(EUCOMM)Wtsi/Tcp) 		impaired glucose tolerance J:211773
4833411C07Rikem1Cecad/4833411C07Rikem1Cecad
(C57BL/6N-4833411C07Rikem1Cecad) 		impaired glucose tolerance J:285483
increased circulating glucose level J:285483
insulin resistance J:285483
4930505A04Riktm1b(KOMP)Wtsi/4930505A04Riktm1b(KOMP)Wtsi
(C57BL/6N-4930505A04Riktm1b(KOMP)Wtsi/Bay) 		decreased circulating glucose level J:211773
4930563E22Riktm1.1(KOMP)Vlcg/4930563E22Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4930563E22Riktm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
4932438A13Riktm1b(EUCOMM)Hmgu/4932438A13Rik+
(C57BL/6N-4932438A13Riktm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
4933402J07Rikem1(IMPC)J/4933402J07Rikem1(IMPC)J
(C57BL/6NJ-4933402J07Rikem1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
a/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		decreased circulating glucose level J:168271
improved glucose tolerance J:168271
a/Ay
Guq1KK/Guq1KK
(involves: C57BL/6J * KK-Ay) 		increased urine glucose level J:131439
a/Ay
Guq2C57BL/6J/Guq2C57BL/6J
(involves: C57BL/6J * KK-Ay) 		increased urine glucose level J:131439
A1cftm1c(EUCOMM)Hmgu/A1cftm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6N * DBA) 		decreased circulating glucose level J:281365
decreased circulating insulin level J:281365
decreased fasting circulating glucose level J:281365
impaired gluconeogenesis J:281365
improved glucose tolerance J:281365
increased insulin sensitivity J:281365
increased liver glycogen level J:281365
Ay/a
(involves: KK) 		hyperglycemia J:26460
impaired glucose tolerance J:26460
increased circulating insulin level J:26460
increased urine glucose level J:26460
insulin resistance J:26460
Ay/a
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl) 		hyperglycemia J:177084
increased circulating insulin level J:177084
insulin resistance J:177084
Ay/a
Rmi1Gt(pUHachi)0283Imeg/Rmi1+
(involves: C57BL/6 * KK) 		decreased circulating glucose level J:168271
improved glucose tolerance J:168271
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl) 		impaired glucose tolerance J:211773
Aasdhppttm1.1(KOMP)Vlcg/Aasdhppt+
(B6N(Cg)-Aasdhppttm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
Abca7tm2b(EUCOMM)Hmgu/Abca7tm2b(EUCOMM)Hmgu
(B6N(Cg)-Abca7tm2b(EUCOMM)Hmgu/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H) 		decreased circulating glucose level J:211773
Abcb11tm1Wng/Abcb11tm1Wng
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased liver glycogen level J:67548
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H) 		decreased circulating glucose level J:211773
impaired glucose tolerance J:211773
Abcc8em1(IMPC)J/Abcc8em1(IMPC)J
(C57BL/6NJ-Abcc8em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas) 		decreased circulating glucose level J:208932
decreased insulin secretion J:208932
impaired glucose tolerance J:208932
increased circulating glucose level J:208932
increased insulin secretion J:208932
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6) 		decreased insulin secretion J:79352
hypoglycemia J:79352
impaired glucose tolerance J:79352
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ * C57BL/6) 		hypoglycemia J:61356
impaired glucose tolerance J:61356
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ) 		abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc8tm1Jbry/Abcc8tm1Jbry
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129X1/SvJ) 		abnormal insulin secretion J:179577
decreased circulating glucose level J:179577
decreased insulin secretion J:179577
increased circulating glucose level J:179577
Abcc9tm1Cfb/Abcc9tm1Cfb
(involves: CD-1) 		hypoglycemia J:71840
improved glucose tolerance J:71840
increased insulin sensitivity J:71840
Abcd3em1(IMPC)J/Abcd3em1(IMPC)J
(C57BL/6NJ-Abcd3em1(IMPC)J/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Abcg1tm1Asch/Abcg1tm1Asch
(involves: 129X1/SvJ * C57BL/6) 		hypoglycemia J:122438
Abcg2em1Omw/Abcg2em1Omw
(C57BL/6J-Abcg2em1Omw) 		increased circulating glucose level J:292268
increased circulating insulin level J:292268
Abcg2tm1.1Ssf/Abcg2tm1.1Ssf
(involves: 129 * C57BL/6 * FVB) 		abnormal glucose homeostasis J:201884
decreased liver glycogen level J:201884
impaired glucose tolerance J:201884
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz) 		increased fasting circulating glucose level J:211773
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:160725
Abhd5tm1Rze/Abhd5tm1Rze
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		abnormal glucose homeostasis J:197835
decreased circulating glucose level J:197835
decreased circulating insulin level J:197835
improved glucose tolerance J:197835
Abhd6tm1a(EUCOMM)Hmgu/Abhd6+
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		increased insulin secretion J:215257
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu) 		decreased circulating insulin level J:234876
decreased insulin secretion J:234876
improved glucose tolerance J:234876
increased circulating insulin level J:215257
increased insulin secretion J:215257, J:234876
increased insulin sensitivity J:234876
Abhd6tm1c(EUCOMM)Hmgu/Abhd6tm1c(EUCOMM)Hmgu
Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6N * CD-1) 		improved glucose tolerance J:215257
increased circulating insulin level J:215257
increased insulin secretion J:215257
Abhd11tm1Esco/Abhd11tm1Esco
(involves: C57BL/6) 		decreased circulating glucose level J:294591
decreased circulating insulin level J:294591
improved glucose tolerance J:294591
increased insulin sensitivity J:294591
Abhd12bem1(IMPC)J/Abhd12bem1(IMPC)J
(C57BL/6NJ-Abhd12bem1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Abhd14atm2a(EUCOMM)Wtsi/Abhd14atm2a(EUCOMM)Wtsi
(C57BL/6N-Abhd14atm2a(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(C57BL/6N-Abhd16atm1a(EUCOMM)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Abhd17atm1a(KOMP)Wtsi/Abhd17atm1a(KOMP)Wtsi
(C57BL/6N-Abhd17atm1a(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Abtb1em1(IMPC)Ccpcz/Abtb1em1(IMPC)Ccpcz
(C57BL/6N-Abtb1em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Acacatm2Sjw/Acacatm2Sjw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S7/SvEvBrd * C57BL/6J * FVB) 		abnormal glucose homeostasis J:110200
hyperglycemia J:110200
increased circulating insulin level J:110200
Acacbtm1.1Dejs/Acacbtm1.1Dejs
(B6.Cg-Acacbtm1.1Dejs) 		abnormal glucose homeostasis J:157000
increased skeletal muscle glycogen level J:157000
Acacbtm1.2Lowl/Acacbtm1.2Lowl
(involves: 129S6/SvEvTac * FVB/N) 		increased circulating insulin level J:159285
Acacbtm1Sjw/Acacbtm1Sjw
(Not Specified) 		decreased circulating glucose level J:68427
decreased liver glycogen level J:68427
Acad12tm1b(EUCOMM)Wtsi/Acad12tm1b(EUCOMM)Wtsi
(C57BL/6N-Acad12tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Acadltm1Uab/Acadltm1Uab
(involves: 129S6/SvEvTac * C57BL/6NTac) 		hypoglycemia J:51660
Acadmtm1Uab/Acadmtm1Uab
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:115759
Acadsdel-J/Acadsdel-J
(involves: BALB/cByJ) 		hypoglycemia J:14707
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * C57BL/6) 		impaired glucose tolerance J:102010
Acadvltm1Vje/Acadvltm1Vje
(involves: 129/Sv * Black Swiss * C57BL/6) 		decreased glycogen level J:106714
hypoglycemia J:106714
Acadvltm1Zkhu/Acadvltm1Zkhu
Tg(Myh6-cre)1Jmk/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCr) 		decreased circulating glucose level J:208711
Acap1tm1.1(KOMP)Vlcg/Acap1tm1.1(KOMP)Vlcg
(B6N(Cg)-Acap1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased insulin secretion J:128859
Acetm3Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased insulin secretion J:128859
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL) 		abnormal glucose homeostasis J:203753
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating glucose level J:182660
improved glucose tolerance J:182660
Acot13tm1Deco/Acot13tm1Deco
(involves: 129 * C57BL/6) 		abnormal gluconeogenesis J:183258
abnormal glucose homeostasis J:183258
improved glucose tolerance J:183258
Acox3em1(IMPC)J/Acox3em1(IMPC)J
(C57BL/6NJ-Acox3em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Acoxlem1(IMPC)Mbp/Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd) 		improved glucose tolerance J:211773
Acsl1tm1Rcol/Acsl1tm1Rcol
Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6) 		hypoglycemia J:162996
Acsl5tm1.1(KOMP)Vlcg/Acsl5tm1.1(KOMP)Vlcg
(C57BL/6N-Acsl5tm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
Acsm2tm1.1(KOMP)Vlcg/Acsm2tm1.1(KOMP)Vlcg
(B6N(Cg)-Acsm2tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Acss1tm1Jsak/Acss1tm1Jsak
(B6.129-Acss1tm1Jsak) 		hypoglycemia J:146647
Acta1tm1Jll/Acta1tm1Jll
(involves: 129P2/OlaHsd * Black Swiss) 		decreased glycogen level J:78070
decreased liver glycogen level J:78070
decreased skeletal muscle glycogen level J:78070
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Camk2a-cre)#Szi/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J * CBA) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Hsp70-1-cre)6Arge/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * SJL) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm1(INSR)Dac/Actbtm1(INSR)Dac
Insrtm1Dac/Insrtm1Dac
Tg(Syn1-cre)671Jxm/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA) 		increased circulating glucose level J:91350
increased circulating insulin level J:91350
Actbtm3.1(Sirt1)Npa/Actb+
(involves: 129/Sv * C57BL/6 * C57BL/6J) 		decreased circulating insulin level J:160212
decreased fasting circulating glucose level J:160212
improved glucose tolerance J:160212
Ad/Ad
(involves: Chr 7 marker stock * Wild stock) 		increased circulating insulin level J:6095
Ad/Ad+
(involves: Chr 7 marker stock * Wild stock) 		increased circulating insulin level J:6095
Adam26atm1.1(KOMP)Vlcg/Adam26atm1.1(KOMP)Vlcg
(C57BL/6N-Adam26atm1.1(KOMP)Vlcg/Ucd) 		increased circulating glucose level J:211773
Adamtsl5tm1b(EUCOMM)Hmgu/Adamtsl5tm1b(EUCOMM)Hmgu
(C57BL/6N-Adamtsl5tm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Adartm1b(EUCOMM)Wtsi/Adar+
(B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J) 		decreased circulating glucose level J:211773
Adartm1Knk/Adartm1Knk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		hyperglycemia J:87714
Adcy3Jll/Adcy3+
(involves: 129S1/SvImJ * C57BL/6J) 		decreased circulating glucose level J:223554
decreased circulating insulin level J:223554
Adcy9tm1b(EUCOMM)Wtsi/Adcy9+
(C57BL/6N-Adcy9tm1b(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Adcyap1tm1Eid/Adcyap1tm1Eid
(involves: 129S4/SvJae * C57BL/6) 		hypoglycemia J:73702
Adcyap1tm1Nms/Adcyap1tm1Nms
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: C57BL/6)) 		decreased liver glycogen level J:71968
hypoglycemia J:71968
increased circulating insulin level J:71968
Adcyap1r1tm1Bbt/Adcyap1r1tm1Bbt
(involves: 129 * C57BL/6J) 		decreased circulating insulin level J:62115
impaired glucose tolerance J:62115
increased circulating insulin level J:62115
Adgra1tm1b(EUCOMM)Hmgu/Adgra1tm1b(EUCOMM)Hmgu
(B6N(Cg)-Adgra1tm1b(EUCOMM)Hmgu/J) 		improved glucose tolerance J:211773
Adgrb1tm2a(EUCOMM)Wtsi/Adgrb1tm2a(EUCOMM)Wtsi
(C57BL/6N-Adgrb1tm2a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Adgrb2tm1b(KOMP)Mbp/Adgrb2tm1b(KOMP)Mbp
(B6N(Cg)-Adgrb2tm1b(KOMP)Mbp/J) 		decreased fasting circulating glucose level J:211773
Adgrf5m1Btlr/Adgrf5m1Btlr
(C57BL/6J-Adgrf5m1Btlr) 		increased circulating glucose level J:225045
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp) 		increased fasting circulating glucose level J:211773
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
(B6J.B6N-Adigtm1.1(KOMP)Vlcg) 		decreased circulating insulin level J:304292
improved glucose tolerance J:304292
increased insulin sensitivity J:304292
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
Lepob/Lepob
(B6.Cg-Adigtm1.1(KOMP)Vlcg Lepob) 		impaired glucose tolerance J:304292
Adip1LG/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x LG/J)F1) 		decreased circulating glucose level J:153477
Adip1SM/J/?
Capn10tm1Chev/Capn10+
((B6.129-Capn10tm1Chev x SM/J)F1) 		decreased circulating glucose level J:153477
Adipoqtm1Far/Adipoqtm1Far
(involves: C57BL/6J) 		impaired glucose tolerance J:111346
Adipoqtm1Far/Adipoqtm1Far
(involves: 129S4/SvJae * C57BL/6J) 		impaired glucose tolerance J:111346
increased circulating glucose level J:111346
Adipoqtm1Far/Adipoqtm1Far
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		abnormal glucose tolerance J:111346
decreased circulating glucose level J:111346
Adipoqtm1Ish/Adipoq+
Bglap/Bglap2tm1Kry/Bglap+
(involves: 129S7/SvEvBrd) 		insulin resistance J:126780
Adipoqtm1Ish/Adipoq+
Bglap/Bglap2tm1Kry/Bglap2+
(involves: 129S7/SvEvBrd) 		insulin resistance J:126780
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal glucose homeostasis J:199264
decreased insulin secretion J:199264
hyperglycemia J:77479, J:103106
impaired glucose tolerance J:199264
increased circulating glucose level J:106599
increased circulating insulin level J:77479
insulin resistance J:77479
Adipoqtm1Ish/Adipoqtm1Ish
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:199264
increased circulating glucose level J:199264
Adipoqtm1Pesch/Adipoqtm1Pesch
(involves: 129S7/SvEvBrd) 		abnormal gluconeogenesis J:107486
impaired glucose tolerance J:107486
Adipoqtm1Pesch/Adipoqtm1Pesch
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6J) 		impaired glucose tolerance J:107486
Adipoqtm1Tka/Adipoq+
(involves: 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:77876
insulin resistance J:77876
Adipoqtm1Tka/Adipoqtm1Tka
(involves: 129S4/SvJae * C57BL/6) 		impaired glucose tolerance J:77876
insulin resistance J:77876
Adipor1tm1Dgen/Adipor1tm1Dgen
(B6.129P2-Adipor1tm1Dgen/Mmnc) 		impaired glucose tolerance J:122027
Adipor1tm1Tka/Adipor1tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:117919
hyperglycemia J:117919
impaired glucose tolerance J:117919
increased circulating glucose level J:117919
increased circulating insulin level J:117919
insulin resistance J:117919
Adipor1tm1Tka/Adipor1tm1Tka
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		abnormal circulating glucose level J:117919
abnormal gluconeogenesis J:117919
abnormal glucose homeostasis J:117919
hyperglycemia J:117919
impaired glucose tolerance J:117919
insulin resistance J:117919
Adipor1tm2Tka/Adipor1tm2Tka
Tg(Ckmm-cre)5Khn/0
(B6.Cg-Adipor1tm2Tka Tg(Ckmm-cre)5Khn) 		abnormal glucose homeostasis J:159462
increased circulating glucose level J:159462
increased circulating insulin level J:159462
insulin resistance J:159462
Adipor2tm1Dgen/Adipor2tm1Dgen
(B6.129P2-Adipor2tm1Dgen) 		decreased circulating insulin level J:122027
improved glucose tolerance J:122027
Adipor2tm1Tka/Adipor2tm1Tka
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:117919
hyperglycemia J:117919
impaired glucose tolerance J:117919
increased circulating insulin level J:117919
insulin resistance J:117919
Adipor2tm2Dgen/Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:129554
decreased circulating insulin level J:129554
increased circulating glucose level J:129554
Adora2aem1(IMPC)H/Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H) 		increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Adora2btm1.1(KOMP)Vlcg/Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Adora2btm1.1(KOMP)Vlcg/Adora2btm1.1(KOMP)Vlcg
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:87718
decreased skeletal muscle glycogen level J:87718
hyperglycemia J:87718
impaired glucose tolerance J:87718
increased circulating insulin level J:87718
increased liver glycogen level J:87718
insulin resistance J:87718
Adra2am1Btlr/Adra2am1Btlr
(C57BL/6J-Adra2am1Btlr) 		decreased circulating glucose level J:267700
increased circulating insulin level J:267700
Adra2am2Btlr/Adra2am2Btlr
(C57BL/6J-Adra2am2Btlr) 		decreased circulating glucose level J:267701
Adra2atm1.1(KOMP)Vlcg/Adra2atm1.1(KOMP)Vlcg
(C57BL/6N-Adra2atm1.1(KOMP)Vlcg/Ucd) 		decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal glucose homeostasis J:130781
hypoglycemia J:130781
Adrb2tm1Kry/Adrb2+
Lepob/Lep+
Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6 * C57BL/10J * FVB) 		decreased circulating glucose level J:145998
increased circulating insulin level J:145998
Adrb2tm1Kry/Adrb2tm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: FVB) 		abnormal insulin secretion J:145998
decreased circulating glucose level J:145998
increased circulating insulin level J:145998
Afap1l2tm1b(KOMP)Wtsi/Afap1l2tm1b(KOMP)Wtsi
(C57BL/6N-Afap1l2tm1b(KOMP)Wtsi/Ucd) 		improved glucose tolerance J:211773
Afmidtm1a(EUCOMM)Wtsi/Afmidtm1a(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1a(EUCOMM)Wtsi/H) 		hyperglycemia J:226537
Afmidtm1b(EUCOMM)Wtsi/Afmid+
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:226537
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H) 		decreased insulin secretion J:226537
impaired glucose tolerance J:226537
increased circulating glucose level J:211773, J:226537
Afptm1(Cebpa)Ndw/Afp+
(involves: 129S7/SvEvBrd) 		increased liver glycogen level J:103404
Agap2tm1.1Kye/Agap2tm1.1Kye
(Not Specified) 		abnormal gluconeogenesis J:174775
hyperglycemia J:174775
increased insulin sensitivity J:174775
insulin resistance J:174775
Agap2tm1Kye/Agap2tm1Kye
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA/2) 		abnormal gluconeogenesis J:174775
hyperglycemia J:174775
impaired glucose tolerance J:174775
increased circulating insulin level J:174775
insulin resistance J:174775
Agertm1.1Arnd/Agertm1.1Arnd
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:82491
Agertm1.1Hyam/Ager+
Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2) 		hyperglycemia J:116040
Agertm1.1Hyam/Agertm1.1Hyam
(involves: 129P2/OlaHsd * C57BL/6J * CD-1) 		increased circulating glucose level J:116507
Agertm1.1Hyam/Agertm1.1Hyam
Tg(Ins2-Nos2)40Okam/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA/2) 		hyperglycemia J:116040
Agltm1a(EUCOMM)Wtsi/Agltm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		hypoglycemia J:212003
increased cardiac muscle glycogen level J:212003
increased liver glycogen level J:212003
increased skeletal muscle glycogen level J:212003
Agltm1b(EUCOMM)Wtsi/Agltm1b(EUCOMM)Wtsi
(C57BL/6N-Agltm1b(EUCOMM)Wtsi/H) 		decreased circulating glucose level J:211773
impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Agltm1Geno/Agltm1Geno
(C57BL/6J-Agltm1Geno) 		decreased circulating glucose level J:218471
decreased fasting circulating glucose level J:218471
increased brain glycogen level J:218471
increased cardiac muscle glycogen level J:218471
increased glycogen level J:218471
increased liver glycogen level J:218471
increased skeletal muscle glycogen level J:218471
Ago2tm1.1Tara/Ago2tm1.1Tara
Lepob/Lepob
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		decreased circulating glucose level J:210552
decreased circulating insulin level J:210552
improved glucose tolerance J:210552
increased circulating insulin level J:210552
Ago2tm1.1Tara/Ago2tm1.1Tara
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		improved glucose tolerance J:210552
Agpat1tm1.1(KOMP)Vlcg/Agpat1+
(B6N(Cg)-Agpat1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased urine glucose level J:211773
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6) 		decreased circulating glucose level J:250301
hypoglycemia J:250301
impaired gluconeogenesis J:250301
Agpat2Gt(OST438470)Lex/Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		hyperglycemia J:186035
increased circulating glucose level J:186035
increased circulating insulin level J:186035
Agpat2tm1Garg/Agpat2tm1Garg
(involves: 129S6/SvEvTac) 		abnormal glucose homeostasis J:146649
hyperglycemia J:146649
improved glucose tolerance J:231617
increased circulating glucose level J:231617
increased circulating insulin level J:231617, J:146649
insulin resistance J:231617, J:146649
Agpat2tm1Garg/Agpat2tm1Garg
Mogat1tm1Far/Mogat1tm1Far
(involves: 129S4/SvJae * 129S6/SvEvTac) 		improved glucose tolerance J:231617
increased circulating glucose level J:231617
increased circulating insulin level J:231617
insulin resistance J:231617
Agpat4tm1b(KOMP)Wtsi/Agpat4tm1b(KOMP)Wtsi
(C57BL/6N-Agpat4tm1b(KOMP)Wtsi/H) 		increased fasting circulating glucose level J:211773
Agrptm2(DTR)Rpa/Agrp+
Lepob/Lepob
(involves: 129S4/SvJaeSor * C57BL/6) 		improved glucose tolerance J:181947
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd) 		abnormal circulating insulin level J:105210
abnormal glucose homeostasis J:105210
increased insulin sensitivity J:105210
Agtraptm1Tamk/Agtraptm1Tamk
(involves: C57BL/6N) 		increased circulating insulin level J:263253
insulin resistance J:263253
Ahnaktm1b(KOMP)Mbp/Ahnak+
(C57BL/6N-Ahnaktm1b(KOMP)Mbp/H) 		improved glucose tolerance J:211773
Ahsgtm1Mbl/Ahsgtm1Mbl
(B6.129-Ahsgtm1Mbl) 		decreased circulating insulin level J:78087
improved glucose tolerance J:78087
increased insulin sensitivity J:78087
Aidatm1.1Scli/Aidatm1.1Scli
(involves: C57BL/6 * FVB/N) 		hyperglycemia J:262001
increased circulating insulin level J:262001
increased liver glycogen level J:262001
insulin resistance J:262001
Aifm1tm2Pngr/Y
Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * FVB) 		abnormal glucose homeostasis J:113016
Aifm3em1(IMPC)Rbrc/Aifm3em1(IMPC)Rbrc
(Not Specified) 		increased fasting circulating glucose level J:211773
Ak1tm1Bew/Ak1tm1Bew
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:66101
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6) 		decreased circulating insulin level J:190017
decreased insulin secretion J:190017
improved glucose tolerance J:190017
increased insulin sensitivity J:190017
Akap5tm1Gsm/Akap5tm1Gsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:190017
Akap5tm1Jsco/Akap5tm1Jsco
Tg(Ins2-cre)25Mgn/0
(involves: 129S * C57BL/6 * DBA) 		decreased circulating insulin level J:190017
impaired glucose tolerance J:190017
increased insulin secretion J:190017
Akap5tm1Mdaq/Akap5tm1Mdaq
(involves: 129 * C57BL/6 * C57BL/6J) 		decreased circulating insulin level J:190017
decreased insulin secretion J:190017
improved glucose tolerance J:190017
increased insulin sensitivity J:190017
Akap9tm1a(KOMP)Wtsi/Akap9+
(involves: C57BL/6 * C57BL/6N) 		decreased circulating glucose level J:213427
Akr1b7tm1.1Anm/Akr1b7tm1.1Anm
(involves: 129) 		increased circulating insulin level J:208505
insulin resistance J:208505
Akr1b8tm1.1(KOMP)Vlcg/Akr1b8tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1b8tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Akr1d1tm1.1(KOMP)Vlcg/Akr1d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Akr1d1tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ) 		decreased insulin secretion J:149156
hyperglycemia J:149156
impaired glucose tolerance J:149156
increased circulating insulin level J:149156
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg
Akt3tm1Nhy/Akt3tm1Nhy
(involves: 129/Sv * C57BL/6 * DBA/1LacJ) 		hyperglycemia J:149156
Akt1tm1Nhy/Akt1+
Akt2tm1Rsg/Akt2tm1Rsg
Ptentm1Ppp/Pten+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ) 		impaired glucose tolerance J:149156
increased circulating insulin level J:149156
Akt1tm2.1Mbb/Akt1tm2.1Mbb
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		abnormal gluconeogenesis J:182721
abnormal glucose homeostasis J:182721
improved glucose tolerance J:182721
increased insulin sensitivity J:182721
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:71491
impaired glucose tolerance J:71491
increased circulating insulin level J:71491
insulin resistance J:71491
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(involves: 129P2/OlaHsd) 		hyperglycemia J:160759
impaired glucose tolerance J:160759
Akt2tm1.1Mbb/Akt2tm1.1Mbb
(B6.129P2-Akt2tm1.1Mbb) 		decreased circulating glucose level J:155432
increased circulating insulin level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Lepob/Lepob
(B6.Cg-Lepob Akt2tm1.1Mbb) 		increased circulating glucose level J:155432
increased circulating insulin level J:155432
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Ptentm1Hwu/Ptentm1Hwu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		hyperglycemia J:160759
impaired glucose tolerance J:160759
Akt2tm1.2Mbb/Akt2tm1.2Mbb
Lepob/Lepob
Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * SJL) 		increased circulating glucose level J:155432
Akt2tm1Hem/Akt2tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:114675
impaired glucose tolerance J:114675
increased circulating insulin level J:114675
insulin resistance J:114675
Akt2tm1Hem/Akt2tm1Hem
Akt3tm1Hem/Akt3tm1Hem
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:114675
impaired glucose tolerance J:114675
increased circulating insulin level J:114675
insulin resistance J:114675
Akt2tm1Rsg/Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg) 		abnormal glucose homeostasis J:84606
decreased circulating insulin level J:84606
hyperglycemia J:84606
impaired glucose tolerance J:84606
increased circulating insulin level J:84606
insulin resistance J:84606
Akt2tm1Rsg/Akt2tm1Rsg
(involves: C57BL/6 * DBA/1LacJ) 		impaired glucose tolerance J:149156
increased circulating insulin level J:149156
insulin resistance J:149156
Akt2tm1Rsg/Akt2tm1Rsg
Akt3tm1Nhy/Akt3tm1Nhy
(involves: 129/Sv * C57BL/6 * DBA/1LacJ) 		impaired glucose tolerance J:149156
Akt2tm1Rsg/Akt2tm1Rsg
Ptentm1Ppp/Pten+
(involves: 129S1/Sv * C57BL/6 * DBA/1LacJ) 		decreased circulating insulin level J:149156
impaired glucose tolerance J:149156
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz
Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		abnormal circulating glucose level J:197607
abnormal glucose homeostasis J:197607
abnormal glycogen homeostasis J:197607
decreased insulin secretion J:197607
impaired glucose tolerance J:197607
increased liver glycogen level J:197607
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA) 		decreased insulin secretion J:232360
hyperglycemia J:232360
impaired glucose tolerance J:232360
increased glucagon secretion J:232360
increased insulin secretion J:232360
insulin resistance J:232360
Aldh1b1tm1Vvas/Aldh1b1tm1Vvas
(B6J.Cg-Aldh1b1tm1Vvas) 		increased fasting circulating glucose level J:228677
Alg2tm1.1(KOMP)Vlcg/Alg2+
(B6N(Cg)-Alg2tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
increased circulating insulin level J:211773
Alkbh7tm1.1Klng/Alkbh7tm1.1Klng
(involves: 129S2/SvPas * C57BL/6J) 		abnormal glucose homeostasis J:298649
decreased fasting circulating glucose level J:198968
increased circulating insulin level J:198968
increased hepatic glucose production J:198968
increased insulin sensitivity J:198968
Alms1bbb/Alms1bbb
(C57BL/6JSfdAnu-Alms1bbb/Anu) 		hyperglycemia J:104190
increased circulating insulin level J:104190
Alms1foz/Alms1foz
(involves: NOD) 		hyperglycemia J:107058
increased circulating insulin level J:107058
insulin resistance J:107058
Alms1Gt(XH152)Byg/Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		hyperglycemia J:100403
increased circulating insulin level J:100403
Alms1L2131X/Alms1L2131X
(involves: C57BL/6 * NOD) 		increased circulating insulin level J:118221
Alms1m2Btlr/Alms1m2Btlr
(C57BL/6J-Alms1m2Btlr) 		impaired glucose tolerance J:264648
Alms1m3Btlr/Alms1m3Btlr
(C57BL/6J-Alms1m3Btlr) 		impaired glucose tolerance J:264649
increased circulating insulin level J:264649
increased fasting circulating glucose level J:264649
Alox15tm1.1Nadl/Alox15tm1.1Nadl
Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:224344
increased insulin secretion J:224344
Alx3tm1Hubr/Alx3+
(involves: 129P2/OlaHsd) 		impaired glucose tolerance J:166436
increased circulating glucose level J:166436
Alx3tm1Hubr/Alx3tm1Hubr
(involves: 129P2/OlaHsd) 		decreased insulin secretion J:166436
impaired glucose tolerance J:166436
increased circulating insulin level J:166436
increased fasting circulating glucose level J:166436
insulin resistance J:166436
Anapc2tm1Kna/Anapc2tm2Kna
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased liver glycogen level J:87782
Angptl2tm1Yo/Angptl2tm1Yo
(B6.Cg-Angptl2tm1Yo) 		improved glucose tolerance J:152387
increased insulin sensitivity J:152387
Angptl6tm1Yo/Angptl6tm1Yo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:97552
increased circulating insulin level J:97552
insulin resistance J:97552
Ank2tm2.1Bnt/Ank2+
(STOCK Ank2tm2Bnt/J) 		impaired glucose tolerance J:222913
Ank2tm2.1Bnt/Ank2tm2.1Bnt
(STOCK Ank2tm2Bnt/J) 		abnormal gluconeogenesis J:222913
impaired glucose tolerance J:222913
increased circulating glucose level J:222913
insulin resistance J:222913
Ank2tm3.1Bnt/Ank2+
(B6.129(C)-Ank2tm3.1Bnt/J) 		impaired glucose tolerance J:222913
increased circulating glucose level J:222913
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J) 		abnormal gluconeogenesis J:222913
abnormal glucose homeostasis J:222913
decreased circulating insulin level J:222913
decreased insulin secretion J:222913
impaired glucose tolerance J:222913
increased circulating glucose level J:222913
insulin resistance J:222913
Ankhd1tm1a(KOMP)Wtsi/Ankhd1tm1a(KOMP)Wtsi
(C57BL/6N-Ankhd1tm1a(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Ankib1tm1b(EUCOMM)Hmgu/Ankib1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ankib1tm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Ankrd26Gt(XK525)Byg/Ankrd26Gt(XK525)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating insulin level J:130984
insulin resistance J:130984
anx/anx
(B6C3Fe a/a-anx/J) 		hypoglycemia J:7689
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified) 		increased circulating insulin level J:115806
Anxa7tm1Pll/Anxa7+
(Not Specified) 		decreased insulin secretion J:58572
Ap1m2tm1.1Ohno/Ap1m2tm1.1Ohno
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased circulating glucose level J:226582
Ap1s2em1(IMPC)Mbp/Ap1s2em1(IMPC)Mbp
(C57BL/6N-Ap1s2em1(IMPC)Mbp/MbpMmucd) 		decreased fasting circulating glucose level J:211773
Ap3s1tm1b(EUCOMM)Hmgu/Ap3s1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ap3s1tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ccpcz) 		increased fasting circulating glucose level J:211773
Apbb2M1Btlr/Apbb2M1Btlr
(C57BL/6J-Apbb2M1Btlr) 		impaired glucose tolerance J:265064
Apbb2m2Btlr/Apbb2m2Btlr
(C57BL/6J-Apbb2m2Btlr) 		impaired glucose tolerance J:265072
Apmaptm1.2Jgbs/Apmaptm1.2Jgbs
(B6.129P2-Apmaptm1.2Jgbs) 		decreased circulating glucose level J:247647
improved glucose tolerance J:247647
increased insulin sensitivity J:247647
Apoa2tm1Bres/Apoa2tm1Bres
(involves: 129S4/SvJae) 		decreased circulating glucose level J:37250
decreased circulating insulin level J:37250
Apobtm2Sgy/Apobtm2Sgy
Apoetm1Unc/Apoetm1Unc
Lepob/Lepob
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		hyperglycemia J:133453
impaired glucose tolerance J:133453
increased circulating insulin level J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased circulating insulin level J:227165
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Lepob/Lepob
(involves: 129S7/SvEvBrd * C57BL/6) 		increased circulating insulin level J:133453
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		impaired glucose tolerance J:141333
increased circulating glucose level J:141333
increased circulating insulin level J:141333
Apobtm2Sgy/Apobtm2Sgy
Ldlrtm1Her/Ldlrtm1Her
Tg(Ins-Igf2)1Fbos/?
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL) 		abnormal fasting circulating glucose level J:227165
increased circulating insulin level J:227165
Apoc3tm1Unc/Apoc3tm1Unc
(B6.129-Apoc3tm1Unc/J) 		increased circulating glucose level J:105136
insulin resistance J:105136
Apoc4tm1.1(KOMP)Mbp/Apoc4tm1.1(KOMP)Mbp
(C57BL/6N-Apoc4tm1.1(KOMP)Mbp/Ieg) 		impaired glucose tolerance J:211773
Apoetm1.1Mae/Apoetm1.1Mae
Tg(Fabp4-cre)1Rev/0
(B6.Cg-Apoetm1.1Mae Tg(Fabp4-cre)1Rev) 		decreased circulating glucose level J:219838
decreased circulating insulin level J:219838
improved glucose tolerance J:219838
increased insulin sensitivity J:219838
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		decreased circulating glucose level J:73202
Apoetm1Unc/Apoetm1Unc
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) 		decreased circulating insulin level J:184647
impaired glucose tolerance J:184647
increased circulating glucose level J:184647
insulin resistance J:184647
Apoetm1Unc/Apoetm1Unc
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Apoetm1Unc) 		decreased circulating glucose level J:102223
improved glucose tolerance J:102223
increased insulin sensitivity J:102223
Apoetm1Unc/Apoetm1Unc
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J) 		increased circulating glucose level J:143903
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:151284
impaired glucose tolerance J:151284
Appl1Gt(RRS819)Byg/Appl1Gt(RRS819)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal hepatic glucose production J:211794
impaired glucose tolerance J:211794
increased circulating insulin level J:211794
increased fasting circulating glucose level J:211794
insulin resistance J:211794
Appl2tm1Smoc/Appl2tm1Smoc
Tg(Ckmm-cre)5Khn/0
(involves: FVB) 		improved glucose tolerance J:230004
increased insulin sensitivity J:230004
Aqp1tm1Ask/Aqp1tm1Ask
Aqp7tm1.1Suc/Aqp7tm1.1Suc
(involves: 129S2/SvPas * C57BL/6J) 		increased urine glucose level J:102454
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
Aqp7tm1.1Suc/Aqp7tm1.1Suc
(involves: 129S2/SvPas * C57BL/6J) 		increased urine glucose level J:102454
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased circulating insulin level J:125011
increased insulin secretion J:125011
Aqp7tm1Tfun/Aqp7tm1Tfun
(B6N.129X1-Aqp7tm1Tfun) 		hypoglycemia J:95278
Aqp9tm1Nlsn/Aqp9tm1Nlsn
Leprdb/Leprdb
(involves: 129S1/Sv * C57BL/6 * C57BLKS/J) 		decreased circulating glucose level J:123742
Artm1Chc/Y
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		hyperglycemia J:98775
impaired glucose tolerance J:98775
increased circulating glucose level J:98775
increased circulating insulin level J:98775
insulin resistance J:98775
Artm1Verh/Y
Tg(Fabp4-cre)1Rev/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		hyperglycemia J:196857
impaired glucose tolerance J:196857
increased circulating insulin level J:196857
insulin resistance J:196857
Arel1tm1b(EUCOMM)Hmgu/Arel1tm1b(EUCOMM)Hmgu
(C57BL/6N-Arel1tm1b(EUCOMM)Hmgu/Mhzh) 		increased fasting circulating glucose level J:211773
Arf2tm1.1(KOMP)Wtsi/Arf2tm1.1(KOMP)Wtsi
(B6N(Cg)-Arf2tm1.1(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong) 		abnormal glucose homeostasis J:216529
hyperglycemia J:216529
impaired glucose tolerance J:216529
increased circulating insulin level J:216529
increased insulin secretion J:216529
insulin resistance J:216529
Arhgap17tm1b(EUCOMM)Wtsi/Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Arhgef10tm1.1(KOMP)Vlcg/Arhgef10tm1.1(KOMP)Vlcg
(B6N(Cg)-Arhgef10tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Arhgef11tm1.1Mak/Arhgef11tm1.1Mak
(B6.129P2(C)-Arhgef11tm1.1Mak) 		abnormal glucose homeostasis J:233950
Arid1bem1(IMPC)Tcp/Arid1b+
(C57BL/6NCrl-Arid1bem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Arid3atm1b(KOMP)Wtsi/Arid3a+
(B6N(Cg)-Arid3atm1b(KOMP)Wtsi/J) 		increased circulating insulin level J:211773
Arnt2em1Btlr/Arnt2em1Btlr
(C57BL/6J-Arnt2em1Btlr) 		impaired glucose tolerance J:268298
increased circulating insulin level J:268298
increased fasting circulating glucose level J:268298
Arntltm1.2Shbi/Arntltm1.2Shbi
(involves: C57BL/6J) 		abnormal gluconeogenesis J:177865
abnormal glucose homeostasis J:177865
decreased circulating insulin level J:177865
decreased insulin secretion J:177865
hyperglycemia J:177865
impaired glucose tolerance J:177865
Arntltm1Bra/Arntltm1Bra
(involves: 129) 		abnormal glucose homeostasis J:131694
impaired gluconeogenesis J:131694
increased insulin sensitivity J:131694
Arntltm1Bra/Arntltm1Bra
(involves: 129/Sv * C57BL/6) 		decreased circulating glucose level J:135933
decreased insulin secretion J:162641
Arntltm2Bra/Arntltm2Bra
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA * ICR) 		decreased insulin secretion J:162641
hyperglycemia J:162641
impaired glucose tolerance J:162641
Arpc5ltm1.1(KOMP)Vlcg/Arpc5l+
(B6N(Cg)-Arpc5ltm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Arrdc3Gt(CSE151)Byg/Arrdc3+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:179646
Arrdc3Gt(CSE151)Byg/Arrdc3Gt(CSE151)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose homeostasis J:179646
decreased circulating glucose level J:179646
decreased circulating insulin level J:179646
increased insulin sensitivity J:179646
ArtlesC57BL/6J/?
(involves: C57BL/6J * CAST/Ei) 		increased circulating insulin level J:70961
ArtlesCAST/EiJ/?
(involves: C57BL/6J * CAST/Ei) 		decreased circulating insulin level J:70961
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J) 		decreased fasting circulating glucose level J:263695
improved glucose tolerance J:263695
increased insulin sensitivity J:263695
Arv1tm1.2Radr/Arv1tm1.2Radr
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ) 		decreased fasting circulating glucose level J:241193
hypoglycemia J:241193
improved glucose tolerance J:241193
Arxtm1Gldn/Arxtm1Gldn
Nkx2-2tm2.1Suss/Nkx2-2tm2.1Suss
Tg(Ins2-cre)23Herr/0
(involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL) 		hyperglycemia J:177838
Arxtm1Pgr/Y
(involves: 129/Sv * NMRI) 		hypoglycemia J:86206
Asb7em1(IMPC)Ccpcz/Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Asf1atm1b(KOMP)Wtsi/Asf1a+
(B6N(Cg)-Asf1atm1b(KOMP)Wtsi/2J) 		increased circulating insulin level J:211773
Ash1ltm2b(EUCOMM)Hmgu/Ash1l+
(C57BL/6N-Ash1ltm2b(EUCOMM)Hmgu/Nju) 		increased fasting circulating glucose level J:211773
Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi
(C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(B6Dnk;B6Brd;B6N-Asxl1tm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH) 		decreased circulating glucose level J:175295
Ate1tm1Avar/Ate1tm2.1Avar
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased circulating glucose level J:155421
Atf2tm1b(EUCOMM)Hmgu/Atf2+
(C57BL/6N-Atf2tm1b(EUCOMM)Hmgu/Ccpcz) 		increased fasting circulating glucose level J:211773
Atf2tm1Sis/Atf2+
Creb5tm1Sis/Creb5+
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:156376
increased insulin sensitivity J:156376
Atf3tm1.2Kitab/Atf3tm1.2Kitab
Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA) 		decreased circulating glucose level J:231262
improved glucose tolerance J:231262
increased insulin sensitivity J:231262
Atf4tm1Kry/Atf4tm1Kry
Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6J * FVB) 		abnormal glucose homeostasis J:152695
abnormal glycogen homeostasis J:152695
decreased circulating glucose level J:152695
impaired gluconeogenesis J:152695
improved glucose tolerance J:152695
increased insulin secretion J:152695
increased insulin sensitivity J:152695
Atf4tm1Tow/Atf4+
Ptprvtm1Asmi/Ptprv+
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		decreased circulating glucose level J:152695
increased circulating insulin level J:152695
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		decreased circulating glucose level J:152695
impaired gluconeogenesis J:152695
improved glucose tolerance J:152695
increased circulating insulin level J:152695
increased insulin secretion J:152695
increased insulin sensitivity J:152695
Atf6tm1Hota/Atf6tm1Hota
Tg(Ins2-cre)25Mgn/0
(B6.Cg-Atf6tm1Hota Tg(Ins2-cre)25Mgn) 		increased insulin sensitivity J:213542
Atg5tm1Myok/Atg5tm1Myok
Tg(Kap-cre)1Isa/0
(involves: 129S/SvEv * C57BL/6 * DBA) 		increased urine glucose level J:179961
Atg12tm1.1Jdth/Atg12tm1.1Jdth
Tg(Pomc1-cre)1Gsb/0
(involves: C57BL/6 * FVB/N) 		impaired glucose tolerance J:232686
Atmtm1Pmc/Atm+
(B6.Cg-Atmtm1Pmc) 		impaired glucose tolerance J:222034
insulin resistance J:222034
Atmtm1Pmc/Atmtm1Pmc
(B6.Cg-Atmtm1Pmc) 		impaired glucose tolerance J:222034
insulin resistance J:222034
Atp1a3tm1b(EUCOMM)Hmgu/Atp1a3+
(C57BL/6N-Atp1a3tm1b(EUCOMM)Hmgu/H) 		improved glucose tolerance J:211773
Atp2a2tm1b(EUCOMM)Hmgu/Atp2a2+
(C57BL/6N-Atp2a2tm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Atp5g2tm2b(EUCOMM)Hmgu/Atp5g2+
(C57BL/6N-Atp5g2tm2b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Atp5mdtm1b(EUCOMM)Wtsi/Atp5mdtm1b(EUCOMM)Wtsi
(C57BL/6N-Atp5mdtm1b(EUCOMM)Wtsi/H) 		decreased circulating glucose level J:211773
Atp5otm1.1(KOMP)Vlcg/Atp5o+
(B6N(Cg)-Atp5otm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
Atp8a2wl/Atp8a2wl
(Not Specified) 		hypoglycemia J:14851
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Atpif1em1Jpy/Atpif1em1Jpy
(C57BL/6J-Atpif1em1Jpy) 		improved glucose tolerance J:313048
insulin resistance J:313048
Atrtm1b(KOMP)Wtsi/Atr+
(B6N(Cg)-Atrtm1b(KOMP)Wtsi/2J) 		decreased circulating glucose level J:211773
Atriptm1b(KOMP)Wtsi/Atrip+
(B6N(Cg)-Atriptm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating glucose level J:135320
increased circulating insulin level J:135320
increased insulin secretion J:135320
increased liver glycogen level J:135320
AU021092tm1b(KOMP)Wtsi/AU021092tm1b(KOMP)Wtsi
(C57BL/6N-AU021092tm1b(KOMP)Wtsi/Ucd) 		decreased circulating glucose level J:211773
Avpr2tm1Jwe/Y
(involves: 129S1/Sv * 129X1/SvJ * CF-1) 		hypoglycemia J:66094
Azin2Gt(IST12418H6)Tigm/Azin2Gt(IST12418H6)Tigm
(involves: C57BL/6N) 		decreased circulating insulin level J:204392
B2mtm1Jae/B2mtm1Jae
Tg(B2m)1Rms/0
Tg(INS-cre)2Rms/0
(involves: 129S2/SvPas * NOD) 		abnormal glucose homeostasis J:83635
B2mtm1Unc/B2mtm1Unc
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.Cg-B2mtm1Unc Ciitatm1Ccum) 		abnormal glucose homeostasis J:107051
Baatem1(IMPC)Mbp/Baatem1(IMPC)Mbp
(C57BL/6NCrl-Baatem1(IMPC)Mbp/Mmucd) 		improved glucose tolerance J:211773
Bach1tm1.1(KOMP)Vlcg/Bach1+
(B6N(Cg)-Bach1tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Bach2tm1b(EUCOMM)Wtsi/Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg) 		decreased circulating glucose level J:211773
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae) 		decreased circulating insulin level J:133563
decreased insulin secretion J:133563
increased circulating glucose level J:133563
Badtm1Sjk/Badtm1Sjk
(involves: 129X1/SvJ) 		abnormal circulating glucose level J:133563
decreased insulin secretion J:133563
increased circulating insulin level J:133563
Badtm1Sjk/Badtm1Sjk
Tg(Ins2-Mirc13)E4Biat/0
(involves: 129X1/SvJ * C57BL/6N) 		hyperglycemia J:314874
Badtm2Meg/Badtm2Meg
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased insulin secretion J:133563
impaired glucose tolerance J:133563
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl) 		decreased circulating insulin level J:144416
hypoglycemia J:144416
Baiap2l1tm1Zgh/Baiap2l1tm1Zgh
(B6.Cg-Baiap2l1tm1Zgh) 		impaired glucose tolerance J:238622
increased circulating insulin level J:238622
increased fasting circulating glucose level J:238622
increased hepatic glucose production J:238622
insulin resistance J:238622
Baz1btm2a(KOMP)Wtsi/Baz1b+
(Not Specified) 		decreased circulating glucose level J:165965
Baz2aem1(IMPC)Tcp/Baz2aem1(IMPC)Tcp
(C57BL/6NCrl-Baz2aem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Baz2bem1(IMPC)Wtsi/Baz2bem1(IMPC)Wtsi
(C57BL/6N-Baz2bem1(IMPC)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd) 		increased circulating glucose level J:134093
increased circulating insulin level J:134093
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Bbs10tm1.2Vmar/Bbs10tm1.2Vmar
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glucose tolerance J:227230
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6) 		increased circulating glucose level J:189019
increased insulin sensitivity J:189019
BC048562tm1b(KOMP)Wtsi/BC048562tm1b(KOMP)Wtsi
(C57BL/6N-BC048562tm1b(KOMP)Wtsi/Bay) 		decreased fasting circulating glucose level J:211773
Bcat2tm1.2Clyn/Bcat2tm1.2Clyn
(involves: BALB/cJ * C57BL/6J * C57BL/6N) 		abnormal glucose homeostasis J:129967
decreased circulating glucose level J:129967
decreased circulating insulin level J:129967
improved glucose tolerance J:129967
increased insulin sensitivity J:129967
Bckdhatm1a(EUCOMM)Hmgu/Bckdhatm1a(EUCOMM)Hmgu
Tg(Ucp1-cre)1Evdr/0
(involves: C57BL/6N * FVB) 		impaired glucose tolerance J:278806
insulin resistance J:278806
Bcl2tm1.1Sjk/Bcl2tm1.1Sjk
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6NCrj * SJL) 		abnormal circulating glucose level J:181308
abnormal circulating insulin level J:181308
abnormal glucose homeostasis J:181308
abnormal glucose tolerance J:181308
Bcl6tm1Gdba/Bcl6tm1Gdba
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		decreased circulating insulin level J:271078
decreased fasting circulating glucose level J:271078
impaired gluconeogenesis J:271078
increased insulin sensitivity J:271078
Bcl11btm1.1(KOMP)Vlcg/Bcl11b+
(B6N(Cg)-Bcl11btm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		decreased liver glycogen level J:189652
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp) 		decreased circulating glucose level J:273501
Bdnftm1Par/Bdnf+
(B6.129S1-Bdnftm1Par) 		increased circulating insulin level J:59077
Bdnftm3Jae/Bdnftm3Jae
Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * CBA/J) 		increased circulating glucose level J:71969
increased circulating insulin level J:71969
insulin resistance J:71969
Becn2tm1.1Blev/Becn2+
(B6.Cg-Becn2tm1.1Blev) 		impaired glucose tolerance J:203842
increased circulating glucose level J:203842
insulin resistance J:203842
Betalinc1tm1Suss/Betalinc1tm1Suss
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:231585
increased circulating insulin level J:231585
insulin resistance J:231585
Bfq1LP/J/Bfq1LP/J
(involves: C57BL/10SnJ * LP/J) 		decreased circulating insulin level J:42700
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:126780
decreased circulating insulin level J:126780
decreased insulin secretion J:126780
impaired glucose tolerance J:126780
increased circulating glucose level J:126780
insulin resistance J:126780
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
Tg(AZIP/F)1Vsn/0
(involves: 129S7/SvEvBrd * FVB/N) 		increased circulating insulin level J:145998
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:126780
decreased circulating insulin level J:126780
decreased insulin secretion J:126780
impaired glucose tolerance J:126780
increased circulating glucose level J:126780
insulin resistance J:126780
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
Tg(AZIP/F)1Vsn/0
(involves: 129S7/SvEvBrd * FVB/N) 		increased circulating insulin level J:145998
Bglu1C57BL/6Slc/Bglu1C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu1C57BL/6Slc/Bglu1C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu2C57BL/6Slc/Bglu2C3H/HeSlc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu2C57BL/6Slc/Bglu2C57BL/6Slc
(involves: C3H/HeSlc * C57BL/6Slc) 		hyperglycemia J:62933
Bglu3C3H/HeJ/Bglu3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J) 		increased circulating glucose level J:108422
Bglu3C3H/HeJ/Bglu3C57BL/6J
(involves: C3H/HeJ * C57BL/6J) 		increased circulating glucose level J:108422
Bglu4NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu5NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu6NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu7NZW/LacJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu8NZB/BlNJ/Bglu8NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu8NZW/LacJ/Bglu8NZW/LacJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu10NZB/BlNJ/?
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bglu11NZB/BlNJ/Bglu11NZB/BlNJ
Bglu9NZB/BlNJ/Bglu9NZB/BlNJ
(involves: NZB/BlNJ * NZW/LacJ) 		increased circulating glucose level J:138463
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(B6N(Cg)-Bhlhe40tm1b(KOMP)Wtsi/J) 		decreased fasting circulating glucose level J:211773
Bivmtm1b(KOMP)Wtsi/Bivmtm1b(KOMP)Wtsi
(C57BL/6N-Bivmtm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Blvratm1c(EUCOMM)Hmgu/Blvratm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6J * C57BL/6N) 		decreased liver glycogen level J:237631
impaired glucose tolerance J:237631
increased circulating insulin level J:237631
increased fasting circulating glucose level J:237631
insulin resistance J:237631
Bmp4tm1Blh/Bmp4+
(involves: 129S2/SvPas * C57BL/6) 		increased circulating glucose level J:173500
Bmp10tm3b(EUCOMM)Hmgu/Bmp10+
(C57BL/6N-Bmp10tm3b(EUCOMM)Hmgu/Ics) 		improved glucose tolerance J:211773
Bnip3em1(IMPC)Mbp/Bnip3em1(IMPC)Mbp
(C57BL/6N-Bnip3em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Bola2tm1(KOMP)Wtsi/Bola2tm1(KOMP)Wtsi
(C57BL/6N-Bola2tm1(KOMP)Wtsi/Nju) 		improved glucose tolerance J:211773
Bola3tm1a(EUCOMM)Wtsi/Bola3tm1a(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * C57BL/6N * FVB/NJ) 		impaired glucose tolerance J:287367
Bpifcem1(IMPC)J/Bpifcem1(IMPC)J
(C57BL/6NJ-Bpifcem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Braftm1Sva/Braftm1.1Sva
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		hypoglycemia J:121660
Braftm1Wds/Braftm1.1Wds
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		hypoglycemia J:121660
Brd2Gt(RRT234)Byg/Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg) 		decreased circulating glucose level J:159964
improved glucose tolerance J:159964
increased circulating glucagon level J:159964
increased circulating insulin level J:159964
Brpf3tm1a(EUCOMM)Wtsi/Brpf3+
(B6JTyr;B6N-Brpf3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Brs3tm1Hoh/Brs3tm1Hoh
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:44242
increased circulating insulin level J:44242
Brs3tm1Jfb/Brs3tm1Jfb
(B6.129X1-Brs3tm1Jfb) 		increased circulating insulin level J:134021
Bscl2tm1.1Gliu/Bscl2tm1.1Gliu
Tg(Fabp4-cre)1Rev/0
(involves: 129 * 129S4/SvJaeSor) 		increased circulating insulin level J:211072
Bscl2tm1.1Lchan/Bscl2tm1.1Lchan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal glucose homeostasis J:183701
decreased circulating glucose level J:183701
increased circulating glucose level J:183701
increased circulating insulin level J:183701
insulin resistance J:183701
Bscl2tm1.2Gliu/Bscl2tm1.2Gliu
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		impaired glucose tolerance J:173404
increased circulating glucose level J:173404
increased circulating insulin level J:211072, J:173404
insulin resistance J:173404
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics) 		improved glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Bscl2tm1Geno/Bscl2tm1Geno
(B6.129P2-Bscl2tm1Geno) 		hyperglycemia J:200947
impaired glucose tolerance J:200947
increased circulating glucose level J:200947
increased circulating insulin level J:200947
insulin resistance J:200947
Bsxtm1Tre/Bsxtm1Tre
Lepob/Lepob
(B6.Cg-Lepob Bsxtm1Tre) 		hyperglycemia J:122746
increased circulating insulin level J:122746
Btbd9tm1b(EUCOMM)Wtsi/Btbd9tm1b(EUCOMM)Wtsi
(C57BL/6N-Btbd9tm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Btg2tm1b(KOMP)Mbp/Btg2tm1b(KOMP)Mbp
(B6N(Cg)-Btg2tm1b(KOMP)Mbp/2J) 		increased fasting circulating glucose level J:211773
Bub1btm1Jvd/Bub1btm1Jvd
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		hypoglycemia J:234643
improved glucose tolerance J:234643
increased insulin sensitivity J:234643
Bub1btm1Jvd/Bub1btm1Jvd
Mad2l1bptm1.1Itl/Mad2l1bptm1.1Itl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB) 		hypoglycemia J:234643
improved glucose tolerance J:234643
increased insulin sensitivity J:234643
Bud23em2(IMPC)H/Bud23+
(C57BL/6N-Bud23em2(IMPC)H/H) 		decreased circulating glucose level J:211773
Bvestm1.1(KOMP)Vlcg/Bvestm1.1(KOMP)Vlcg
(C57BL/6N-Bvestm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Bwt1HRS/J/Bwt1HRS/J
Find1C57BLKS/J/Find1C57BLKS/J
(involves: C57BLKS/J * HRS/J) 		increased circulating glucose level J:100832
Bzw2tm1b(KOMP)Mbp/Bzw2tm1b(KOMP)Mbp
(B6N(Cg)-Bzw2tm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
C1qatm1b(EUCOMM)Wtsi/C1qatm1b(EUCOMM)Wtsi
(B6N(Cg)-C1qatm1b(EUCOMM)Wtsi/3J) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
C1qtnf1tm1Lex/C1qtnf1tm1Lex
(B6.129S5-C1qtnf1tm1Lex) 		impaired glucose tolerance J:241403
increased circulating insulin level J:241403
insulin resistance J:241403
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased circulating insulin level J:237401
decreased fasting circulating glucose level J:237401
impaired gluconeogenesis J:237401
improved glucose tolerance J:237401
increased insulin secretion J:237401
increased insulin sensitivity J:237401
C1qtnf5tm1.1(KOMP)Vlcg/C1qtnf5+
(B6N(Cg)-C1qtnf5tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
C1qtnf7tm1(KOMP)Vlcg/C1qtnf7tm1(KOMP)Vlcg
(C57BL/6N-C1qtnf7tm1(KOMP)Vlcg) 		decreased circulating glucose level J:244352
improved glucose tolerance J:244352
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg) 		increased circulating insulin level J:212299
increased insulin secretion J:212299
insulin resistance J:212299
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm) 		abnormal glucose homeostasis J:284780
decreased hepatic glucose production J:284780
impaired glucose tolerance J:284780
increased fasting circulating glucose level J:284780
insulin resistance J:284780
C3tm1Hrc/C3tm1Hrc
(involves: 129/Sv * C57BL/6) 		abnormal glucose homeostasis J:60633, J:58966
decreased circulating glucose level J:60633, J:58966
decreased circulating insulin level J:60633
C3tm1Hrc/C3tm1Hrc
(involves: 129) 		decreased circulating insulin level J:87945
C3tm1Hrc/C3tm1Hrc
Lepob/Lepob
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:80546
decreased circulating insulin level J:80546
C5ar2tm1Gdy/C5ar2tm1Gdy
(involves: 129 * C57BL/6) 		abnormal glucose homeostasis J:123294
increased circulating insulin level J:123294
cab/cab
(STOCK Cacna1smdg) 		abnormal glucose homeostasis J:7797
decreased glycogen level J:6195, J:7797
hypoglycemia J:7797
Cabp5tm1b(KOMP)Wtsi/Cabp5tm1b(KOMP)Wtsi
(C57BL/6N-Cabp5tm1b(KOMP)Wtsi/BayMmucd) 		impaired glucose tolerance J:211773
Cacna1atg-rol/Cacna1a+
(involves: C3Hf/Nga * C57BL/6 * SIII) 		abnormal glucose homeostasis J:3611
Cacna1atg-rol/Cacna1atg-rol
(involves: C3Hf/Nga * C57BL/6 * SIII) 		abnormal glucose homeostasis J:3611
Cacna1btm1b(KOMP)Wtsi/Cacna1btm1b(KOMP)Wtsi
(C57BL/6N-Cacna1btm1b(KOMP)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Cacna1btm1Ksw/Cacna1btm1Ksw
(involves: C57BL/6 * CBA) 		decreased circulating glucagon level J:105212
decreased circulating insulin level J:105212
improved glucose tolerance J:105212
Cacna1ctm3Hfm/Cacna1ctm3Hfm
Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating insulin level J:84919
decreased insulin secretion J:84919
impaired glucose tolerance J:84919
increased circulating glucose level J:84919
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating insulin level J:72316
decreased insulin secretion J:72316
impaired glucose tolerance J:72316
increased insulin sensitivity J:72316
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: C57BL/6) 		abnormal glucagon secretion J:95377
decreased circulating glucagon level J:95377
decreased insulin secretion J:95377
impaired glucose tolerance J:95377
increased circulating glucose level J:95377
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: BALB/cJ * C57BL/6) 		decreased glucagon secretion J:101873
decreased insulin secretion J:95636
hyperglycemia J:95636
impaired glucose tolerance J:95636
increased circulating glucose level J:101873
Cacna1ftm1.1(KOMP)Vlcg/Cacna1ftm1.1(KOMP)Vlcg
(C57BL/6N-Cacna1ftm1.1(KOMP)Vlcg/Ucd) 		increased circulating insulin level J:211773
Cacna1stm1.1(KOMP)Vlcg/Cacna1s+
(B6N(Cg)-Cacna1stm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Cacna2d1em1(IMPC)Mbp/Cacna2d1em1(IMPC)Mbp
(C57BL/6N-Cacna2d1em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Cacna2d3tm1b(KOMP)Wtsi/Cacna2d3+
(B6N(Cg)-Cacna2d3tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Cacnb2tm1.1(KOMP)Vlcg/Cacnb2tm1.1(KOMP)Vlcg
(C57BL/6N-Cacnb2tm1.1(KOMP)Vlcg/Tcp) 		impaired glucose tolerance J:211773
Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified) 		decreased insulin secretion J:131014
impaired glucose tolerance J:131014
increased glucagon secretion J:131014
increased insulin sensitivity J:131014
Cadpstm1Bros/Cadps+
Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified) 		abnormal glucose homeostasis J:131014
decreased insulin secretion J:131014
impaired glucose tolerance J:131014
increased glucagon secretion J:131014
increased insulin sensitivity J:131014
Calrtm1Mlk/Calrtm1Mlk
(involves: 129S4/SvJae * C57BL/6J) 		increased cardiac muscle glycogen level J:119647
Camk1tm2b(EUCOMM)Hmgu/Camk1tm2b(EUCOMM)Hmgu
(C57BL/6N-Camk1tm2b(EUCOMM)Hmgu/Bay) 		decreased fasting circulating glucose level J:211773
Camk2btm1b(EUCOMM)Hmgu/Camk2b+
(C57BL/6N-Camk2btm1b(EUCOMM)Hmgu/Ieg) 		improved glucose tolerance J:211773
Camk4em1(IMPC)Ccpcz/Camk4em1(IMPC)Ccpcz
(C57BL/6N-Camk4em1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Camkk2tm1.1Arm/Camkk2tm1.1Arm
(involves: C57BL/6) 		abnormal glucose homeostasis J:136219
improved glucose tolerance J:136219
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Cand1em1(IMPC)Mbp/Cand1+
(C57BL/6NCrl-Cand1em1(IMPC)Mbp/Mmucd) 		increased fasting circulating glucose level J:211773
Candy/Candy
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy2/Candy2
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy3/Candy3
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy4/Candy4
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:169366
increased urine glucose level J:169366
Candy5/Candy5
(involves: C3H/HeH * C57BL/6J) 		hyperglycemia J:163957
Capn11tm1b(EUCOMM)Wtsi/Capn11tm1b(EUCOMM)Wtsi
(C57BL/6N-Capn11tm1b(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
Capn12tm1b(EUCOMM)Hmgu/Capn12tm1b(EUCOMM)Hmgu
(C57BL/6N-Capn12tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating glucose level J:211773
Car5atm1Sly/Car5atm1Sly
Car5btm1Sly/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating glucose level J:196135
Car5atm1Sly/Car5atm1Sly
Car5btm1Sly/Car5btm1Sly
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating glucose level J:196135
Carmil2tm1b(KOMP)Mbp/Carmil2tm1b(KOMP)Mbp
(C57BL/6N-Carmil2tm1b(KOMP)Mbp/Orl) 		increased circulating glucose level J:211773
Cartpttm1Amgn/Cartpttm1Amgn
(involves: 129X1/SvJ * Black Swiss) 		decreased insulin secretion J:103911
impaired glucose tolerance J:103911
increased circulating insulin level J:103911
Casp4tm1b(KOMP)Wtsi/Casp4tm1b(KOMP)Wtsi
(C57BL/6N-Casp4tm1b(KOMP)Wtsi/Ucd) 		increased circulating glucose level J:211773
increased circulating insulin level J:211773
Casttm1.1(KOMP)Vlcg/Casttm1.1(KOMP)Vlcg
(B6N(Cg)-Casttm1.1(KOMP)Vlcg/2J) 		decreased fasting circulating glucose level J:211773
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6J * SJL) 		increased circulating insulin level J:84260
insulin resistance J:84260
Cav1tm1Mls/Cav1tm1Mls
(FVB.Cg-Cav1tm1Mls) 		abnormal glucose homeostasis J:182288
decreased liver glycogen level J:182288
enhanced gluconeogenesis J:182288
hyperglycemia J:182288
increased circulating insulin level J:182288
increased liver glycogen level J:182288
insulin resistance J:182288
Cav1tm1Pesch/Cav1tm1Pesch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(FVB.Cg-Cav1tm1Pesch Speer6-ps1Tg(Alb-cre)21Mgn) 		decreased circulating glucose level J:182288
Cavin1tm1Pfp/Cavin1tm1Pfp
(involves: 129S6/SvEvTac * C57BL/6) 		impaired glucose tolerance J:143425
increased circulating insulin level J:143425
insulin resistance J:143425
Cbltm1Ddlb/Cbl+
(involves: 129S1/Sv * C57BL/6) 		improved glucose tolerance J:121012
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:94416
decreased circulating insulin level J:94416
improved glucose tolerance J:94416
increased insulin sensitivity J:94416
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * C57BL/6) 		decreased circulating insulin level J:121012
improved glucose tolerance J:121012
increased insulin sensitivity J:121012
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi) 		decreased circulating glucose level J:236022
Cbx5tm1a(EUCOMM)Wtsi/Cbx5tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx5tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Ccar2tm1Dac/Ccar2tm1Dac
(involves: 129 * C57BL/6J) 		impaired glucose tolerance J:228688
increased circulating insulin level J:228688
increased hepatic glucose production J:228688
insulin resistance J:228688
Ccar2tm1Dac/Ccar2tm1Dac
Lepob/Lepob
(involves: 129 * C57BL/6J) 		impaired glucose tolerance J:228688
Ccdc3tm1Ish/Ccdc3tm1Ish
(involves: C57BL/6J) 		abnormal glucose homeostasis J:220560
increased circulating glucose level J:220560
increased insulin sensitivity J:220560
Ccdc50tm1b(EUCOMM)Hmgu/Ccdc50tm1b(EUCOMM)Hmgu
(C57BL/6N-Ccdc50tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Ccdc51em1(IMPC)J/Ccdc51em1(IMPC)J
(C57BL/6NJ-Ccdc51em1(IMPC)J/Mmjax) 		increased fasting circulating glucose level J:211773
Ccdc57tm1a(EUCOMM)Wtsi/Ccdc57+
(B6JTyr;B6N-Ccdc57tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm) 		decreased circulating insulin level J:189183
impaired glucose tolerance J:189183
increased circulating glucose level J:189183
increased insulin secretion J:189183
Ccdc88bem1(IMPC)Tcp/Ccdc88bem1(IMPC)Tcp
(C57BL/6NCrl-Ccdc88bem1(IMPC)Tcp/Tcp) 		decreased fasting circulating glucose level J:211773
Ccdc120tm1.1(KOMP)Vlcg/Y
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Ccdc120tm1.1(KOMP)Vlcg/Ccdc120tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccdc120tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J) 		abnormal gluconeogenesis J:110277
abnormal glucose homeostasis J:126512
decreased circulating insulin level J:110277
impaired glucose tolerance J:126512
improved glucose tolerance J:110277
increased circulating glucose level J:126512
increased circulating insulin level J:126512
increased insulin sensitivity J:110277
Ccl25em1(IMPC)H/Ccl25em1(IMPC)H
(C57BL/6N-Ccl25em1(IMPC)H/H) 		decreased fasting circulating glucose level J:211773
Ccl26tm1.1(KOMP)Vlcg/Ccl26tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccl26tm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
Ccnd2tm1b(KOMP)Mbp/Ccnd2tm1b(KOMP)Mbp
(C57BL/6N-Ccnd2tm1b(KOMP)Mbp/H) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Ccr2tm1.1(CCR2)Rodb/Ccr2tm1.1(CCR2)Rodb
(involves: C57BL/6) 		abnormal glucose homeostasis J:203000
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz/J) 		decreased skeletal muscle glycogen level J:264446
Cd5ltm1b(KOMP)Mbp/Cd5ltm1b(KOMP)Mbp
(C57BL/6N-Cd5ltm1b(KOMP)Mbp/H) 		decreased circulating glucose level J:211773
Cd33tm1.1(KOMP)Vlcg/Cd33tm1.1(KOMP)Vlcg
(B6N(Cg)-Cd33tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Cd36em1(IMPC)Mbp/Cd36em1(IMPC)Mbp
(C57BL/6N-Cd36em1(IMPC)Mbp/MbpMmucd) 		decreased fasting circulating glucose level J:211773
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv * C57BL/6) 		decreased cardiac muscle glycogen level J:83611
decreased fasting circulating glucose level J:56081
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe) 		abnormal gluconeogenesis J:87372
abnormal glucose homeostasis J:87372
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv) 		decreased circulating glucose level J:220343
decreased skeletal muscle glycogen level J:220343
Cd36tm2.1Mfe/Cd36tm2.1Mfe
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(B6.Cg-Cd36tm2.1Mfe A1cfTg(Myh6-cre/Esr1*)1Jmk) 		abnormal glucose homeostasis J:225392
Cd38tm1Lnd/Cd38tm1Lnd
(B6.129P2-Cd38tm1Lnd) 		insulin resistance J:116576
Cd38tm1Okam/Cd38tm1Okam
(involves: C57BL/6 * CBA) 		decreased circulating insulin level J:52933
impaired glucose tolerance J:52933
Cd248tm1.1(KOMP)Vlcg/Cd248tm1.1(KOMP)Vlcg
(C57BL/6N-Cd248tm1.1(KOMP)Vlcg/Ucd) 		increased circulating insulin level J:211773
Cd300etm1.1(KOMP)Vlcg/Cd300etm1.1(KOMP)Vlcg
(C57BL/6N-Cd300etm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
Cdc20tm1.1(KOMP)Vlcg/Cdc20+
(B6N(Cg)-Cdc20tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Cdc34tm1.1(KOMP)Mbp/Cdc34+
(B6N(Cg)-Cdc34tm1.1(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Cdh1tm2Kem/Cdh1tm2Kem
Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		decreased insulin secretion J:196410
impaired glucose tolerance J:196410
Cdh23tm2b(EUCOMM)Wtsi/Cdh23tm2b(EUCOMM)Wtsi
(C57BL/6N-Cdh23tm2b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Cdk4tm1Bbd/Cdk4tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		decreased circulating insulin level J:54534
hyperglycemia J:54534
increased urine glucose level J:54534
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6) 		increased urine glucose level J:57854
Cdk4wnch/Cdk4wnch
(C57BL/6JAnu-Cdk4wnch) 		abnormal glucose homeostasis J:104190
Cdk5rap1tm1.2Tomik/Cdk5rap1tm1.2Tomik
(B6J.Cg-Cdk5rap1tm1.2Tomik) 		decreased circulating glucose level J:220703
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3+
(C57BL/6N-Cdk5rap3tm1b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Tg(Foxa3-cre)1Khk/0
(involves: 129S4/SvJaeSor * C57BL/6N * DBA) 		decreased fasting circulating glucose level J:272566
hypoglycemia J:272566
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu
Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		decreased circulating insulin level J:281075
improved glucose tolerance J:281075
increased circulating glucose level J:281075
increased insulin secretion J:281075
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu
Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6N * FVB/N) 		improved glucose tolerance J:281075
increased insulin secretion J:281075
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj) 		abnormal glucose homeostasis J:195460
decreased circulating glucose level J:195460
decreased circulating insulin level J:195460
decreased insulin secretion J:195460
Cdkal1tm1.1Tomik/Cdkal1tm1.1Tomik
Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn) 		abnormal insulin secretion J:178248
decreased insulin secretion J:178248
impaired glucose tolerance J:178248
increased circulating glucose level J:178248
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * 129S2/SvPas) 		impaired glucose tolerance J:118516
insulin resistance J:118516
Cdkn1btm1Kin/Cdkn1b+
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased circulating glucose level J:96047
increased circulating insulin level J:96047
Cdkn1btm1Kin/Cdkn1b+
Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J) 		hyperglycemia J:96047
increased circulating insulin level J:96047
Cdkn1btm1Kin/Cdkn1btm1Kin
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased circulating glucose level J:96047
increased circulating insulin level J:96047
Cdkn1btm1Kin/Cdkn1btm1Kin
Leprdb/Leprdb
(involves: C57BL/6J * C57BLKS/J) 		increased circulating insulin level J:96047
Cdo1tm1.1Mhst/Cdo1tm1.1Mhst
(involves: C57BL/6) 		decreased circulating glucose level J:182195
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:181979
abnormal glycogen homeostasis J:181979
impaired glucose tolerance J:181979
increased circulating insulin level J:181979
increased insulin secretion J:181979
insulin resistance J:181979
Cebpatm1Gjd/Cebpatm1Gjd
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal gluconeogenesis J:28320
abnormal glucose homeostasis J:28320
abnormal glycogen homeostasis J:28320
decreased liver glycogen level J:28320
hypoglycemia J:28320
Cebpatm1Gonz/Cebpatm1Gonz
Lepob/Lepob
Tg(Alb1-cre)1Dlr/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N) 		decreased circulating insulin level J:93579
impaired glucose tolerance J:93579
increased circulating glucose level J:93579
increased liver glycogen level J:93579
insulin resistance J:93579
Cebpatm1Kgx/Cebpatm1Kgx
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:35795
decreased liver glycogen level J:35795
hypoglycemia J:35795
Cebpatm1Timc/Cebpatm1Timc
(Not Specified) 		decreased circulating glucose level J:163725
Cebpatm6Nerl/Cebpatm6Nerl
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating insulin level J:120098
decreased liver glycogen level J:120098
impaired glucose tolerance J:120098
increased circulating glucose level J:120098
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6) 		hypoglycemia J:136134
Cebpbtm1.1Maka/Cebpbtm1.1Maka
Ins2Akita/Ins2Akita
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J) 		decreased circulating insulin level J:156725
decreased insulin secretion J:156725
increased circulating glucose level J:156725
Cebpbtm1.1Maka/Cebpbtm1.1Maka
Leprdb/Leprdb
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J) 		hyperglycemia J:156725
increased circulating insulin level J:156725
Cebpbtm1.1Maka/Cebpbtm1.1Maka
Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		increased insulin secretion J:156725
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1) 		abnormal gluconeogenesis J:52286
abnormal glucose homeostasis J:62132, J:52286
decreased circulating insulin level J:62132
decreased glycogen catabolism rate J:52286
hypoglycemia J:62132, J:52286
increased insulin sensitivity J:62132
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6 * MF1) 		abnormal gluconeogenesis J:49673
abnormal glucose homeostasis J:49673
hypoglycemia J:49673
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * C57BL/6) 		increased circulating glucose level J:117502
Celtm1Dyh/Celtm1Dyh
Pnliptm1Dyh/Pnliptm1Dyh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased circulating insulin level J:124658
insulin resistance J:124658
Celf4tm1a(EUCOMM)Wtsi/Celf4+
(C57BL/6N-Celf4tm1a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Cenpetm1b(EUCOMM)Hmgu/Cenpe+
(C57BL/6N-Cenpetm1b(EUCOMM)Hmgu/Cnrm) 		increased fasting circulating glucose level J:211773
Cenpjtm1a(EUCOMM)Wtsi/Cenpjtm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cenpjtm1a(EUCOMM)Wtsi/Wtsi) 		abnormal glucose tolerance J:194085
Cenpotm1b(KOMP)Mbp/Cenpo+
(B6N(Cg)-Cenpotm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Cep19tm2.1Jmgi/Cep19tm2.1Jmgi
(involves: C57BL/6NTac) 		impaired glucose tolerance J:206667
increased circulating glucose level J:206667
insulin resistance J:206667
Cep57l1tm1b(KOMP)Wtsi/Cep57l1+
(B6N(Cg)-Cep57l1tm1b(KOMP)Wtsi/2J) 		increased fasting circulating glucose level J:211773
Cept1tm1.1Sem/Cept1tm1.1Sem
Tg(ACTA1-cre)79Jme/0
(involves: C57BL/6J * SJL) 		decreased circulating glucose level J:249456
improved glucose tolerance J:249456
increased insulin sensitivity J:249456
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N) 		decreased circulating insulin level J:215519
improved glucose tolerance J:215519
Cers6tm1Arte/Cers6tm1Arte
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6N * FVB/N) 		improved glucose tolerance J:215519
Ces1dtm1Rile/Ces1dtm1Rile
(involves: 129S6/SvEvTac) 		decreased circulating glucose level J:158743
improved glucose tolerance J:158743
increased insulin sensitivity J:158743
Ces1gtm1Reli/Ces1gtm1Reli
(involves: 129S/SvEv * C57BL/6) 		abnormal glucose homeostasis J:262803
decreased fasting circulating glucose level J:262803
increased circulating insulin level J:262803
increased insulin sensitivity J:262803
insulin resistance J:262803
Cfitm1b(EUCOMM)Hmgu/Cfitm1b(EUCOMM)Hmgu
(C57BL/6N-Cfitm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Chd8em1(IMPC)Mbp/Chd8+
(C57BL/6N-Chd8em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Chgbtm1Ribo/Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6) 		decreased insulin secretion J:157614
impaired glucose tolerance J:157614
Chn1em1(IMPC)J/Chn1+
(C57BL/6NJ-Chn1em1(IMPC)J/J) 		decreased circulating glucose level J:211773
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Chp2tm1b(KOMP)Mbp/Chp2+
(B6N(Cg)-Chp2tm1b(KOMP)Mbp/J) 		decreased fasting circulating glucose level J:211773
Chrdl1em1(IMPC)H/Chrdl1em1(IMPC)H
(C57BL/6NTac-Chrdl1em1(IMPC)H/H) 		increased fasting circulating glucose level J:211773
Chrm3tm1Jwe/Chrm3+
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased circulating insulin level J:91888
decreased insulin secretion J:91888
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glucose homeostasis J:67919
decreased circulating glucagon level J:91888
decreased circulating glucose level J:91888
decreased circulating insulin level J:91888, J:67919
decreased glucagon secretion J:91888
decreased insulin secretion J:91888
improved glucose tolerance J:91888
increased insulin sensitivity J:67919
Chrm3tm2.1Jwe/Chrm3tm2.1Jwe
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N) 		decreased circulating glucose level J:158245
Chrm3tm2Jwe/Chrm3tm2Jwe
Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased insulin secretion J:129643
impaired glucose tolerance J:129643
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Cideatm1Pli/Cideatm1Pli
(involves: 129X1/SvJ) 		abnormal circulating glucose level J:85229
abnormal glucose homeostasis J:85229
Cidebtm1Pli/Cidebtm1Pli
(Not Specified) 		increased insulin sensitivity J:126556
Cidectm1.1Gonz/Cidectm1.2Gonz
Tg(Fabp4-cre)#Abel/?
(B6N.Cg-Cidectm1.1Gonz/Cidectm1.2Gonz Tg(Fabp4-cre)#Abel) 		increased circulating insulin level J:226899
insulin resistance J:226899
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Cidectm1Maka/Cidectm1Maka
(B6.129P2-Cidectm1Maka) 		decreased circulating glucose level J:140863
improved glucose tolerance J:140863
Cidectm1Pli/Cidectm1Pli
(Not Specified) 		improved glucose tolerance J:140122
increased insulin sensitivity J:140122
Cidectm1Pli/Cidectm1Pli
Lepob/Lepob
(involves: C57BL/10J) 		improved glucose tolerance J:140122
increased insulin sensitivity J:140122
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum) 		abnormal circulating glucose level J:106081
Cinptm1.1(KOMP)Vlcg/Cinp+
(B6N(Cg)-Cinptm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Cisd2tm1a(EUCOMM)Wtsi/Cisd2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cisd2tm1a(EUCOMM)Wtsi/H) 		abnormal glucose homeostasis J:165965
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts) 		abnormal glucose homeostasis J:148467
decreased insulin secretion J:148467
impaired glucose tolerance J:148467
increased insulin sensitivity J:148467
Ckmtm1Bew/Ckmtm1Bew
(involves: 129S7/SvEvBrd * C57BL/6) 		increased glycogen catabolism rate J:76699
increased skeletal muscle glycogen level J:76699
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased circulating glucose level J:80901
Clcn5tm1Gug/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased urine glucose level J:66560
Clcn5tm1Tjj/Y
(involves: 129) 		increased urine glucose level J:160701
Clcn5tm2.1Tjj/Y
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased urine glucose level J:160701
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg) 		decreased fasting circulating glucose level J:279934
increased circulating glucose level J:279934
Cldn13em1(IMPC)J/Cldn13em1(IMPC)J
(C57BL/6NJ-Cldn13em1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
Cldn13tm1.1(KOMP)Vlcg/Cldn13tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn13tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Cldnd2tm1b(EUCOMM)Hmgu/Cldnd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Cldnd2tm1b(EUCOMM)Hmgu/Orl) 		increased fasting circulating glucose level J:211773
Clec16aem1(IMPC)J/Clec16a+
(C57BL/6NJ-Clec16aem1(IMPC)J/Mmjax) 		improved glucose tolerance J:211773
Clec16atm1.1Hhak/Clec16atm1.1Hhak
Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL) 		decreased insulin secretion J:214528
hyperglycemia J:214528
impaired glucose tolerance J:214528
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6) 		decreased circulating glucose level J:160186
decreased circulating insulin level J:160186
increased circulating glucagon level J:160186
Clockm1Jt/Clockm1Jt
(C57BL/6-Clockm1Jt) 		increased circulating glucose level J:98343
Clockm1Jt/Clockm1Jt
(involves: C57BL/6) 		abnormal glucose homeostasis J:131694
impaired gluconeogenesis J:131694
increased insulin sensitivity J:131694
Clockm1Jt/Clockm1Jt
(involves: C57BL/6J) 		decreased insulin secretion J:162641
hyperglycemia J:162641
impaired glucose tolerance J:162641
increased insulin sensitivity J:162641
insulin resistance J:162641
Clockm1Jt/Clockm1Jt
Lepob/Lepob
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR) 		decreased circulating glucose level J:135847
decreased circulating insulin level J:135847
increased circulating glucose level J:135847
increased circulating insulin level J:135847
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Clstn3tm1b(EUCOMM)Hmgu/Clstn3tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N) 		decreased circulating glucose level J:293885
increased insulin sensitivity J:293885
Cltrntm1Thu/Y
(involves: 129S/SvEv * C57BL/6) 		increased insulin sensitivity J:148522
Clutm1b(EUCOMM)Hmgu/Clutm1b(EUCOMM)Hmgu
(C57BL/6N-Clutm1b(EUCOMM)Hmgu/H) 		decreased fasting circulating glucose level J:211773
Cluhtm1.1Eir/Cluhtm1.1Eir
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: BALB/cJ * C57BL/6 * DBA * SJL) 		decreased fasting circulating glucose level J:249661
hypoglycemia J:249661
Cluhtm1.2Eir/Cluhtm1.2Eir
(involves: BALB/cJ * C57BL/6 * SJL) 		decreased fasting circulating glucose level J:249661
Clvs1tm1.1(KOMP)Vlcg/Clvs1tm1.1(KOMP)Vlcg
(B6N(Cg)-Clvs1tm1.1(KOMP)Vlcg/J) 		decreased fasting circulating glucose level J:211773
Cnot3tm1.1Tya/Cnot3+
(B6.129P2(Cg)-Cnot3tm1.1Tya) 		decreased circulating glucose level J:180033
decreased fasting circulating glucose level J:180033
improved glucose tolerance J:180033
increased insulin sensitivity J:180033
Cnot3tm1.1Tya/Cnot3+
Lepob/Lepob
(involves: 129P2/OlaHsd * C57BL/6J) 		improved glucose tolerance J:180033
increased insulin sensitivity J:180033
Cnot6ltm1Tya/Cnot6ltm1Tya
(B6.Cg-Cnot6ltm1Tya) 		abnormal circulating glucose level J:274297
abnormal circulating insulin level J:274297
Cnr1tm1Ojm/Cnr1tm1Ojm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased circulating insulin level J:93697
increased insulin sensitivity J:93697
Cog3tm1b(EUCOMM)Hmgu/Cog3+
(C57BL/6N-Cog3tm1b(EUCOMM)Hmgu/Ieg) 		increased circulating insulin level J:211773
Col1a1tm1(tetO-Lin28a)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		decreased circulating glucose level J:166568
decreased circulating insulin level J:166568
improved glucose tolerance J:166568, J:177113
increased insulin sensitivity J:166568, J:177113
Col1a1tm1(tetO-Tcfap2c)Hsc/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		decreased liver glycogen level J:174049
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd) 		decreased circulating glucose level J:217463
Col1a1tm2(CAG-IDH2*R172K)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6) 		increased cardiac muscle glycogen level J:209629
increased skeletal muscle glycogen level J:209629
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		decreased circulating glucose level J:211215
decreased circulating insulin level J:211215
decreased insulin secretion J:211215
improved glucose tolerance J:211215
increased insulin sensitivity J:211215
Col1a1tm2(tetO-LIN28B)Gqda/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		hypoglycemia J:177113
improved glucose tolerance J:177113
increased insulin sensitivity J:177113
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S4/SvJae * BALB/c * C57BL/6) 		increased skeletal muscle glycogen level J:209629
Col1a1tm3(tetO-Fosl1,-DsRed)Wag/Col1a1+
Tg(Cebpb-tTA)5Bjd/0
(involves: 129S4/SvJae * C57BL/6 * NMRI) 		impaired glucose tolerance J:210545
insulin resistance J:210545
Col1a1tm3(tetO-Mirlet7g/Mir21)Gqda/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		impaired glucose tolerance J:177113
increased circulating glucose level J:177113
increased circulating insulin level J:177113
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm) 		impaired glucose tolerance J:211773
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal glucose homeostasis J:171817
decreased circulating insulin level J:171817
decreased insulin secretion J:171817
hyperglycemia J:171817
impaired glucose tolerance J:171817
insulin resistance J:171817
Col6a1tm1Sngi/Col6a1tm1Sngi
(B6.Cg-Col6a1tm1Sngi) 		impaired glucose tolerance J:278926
Col14a1tm1b(KOMP)Wtsi/Col14a1tm1b(KOMP)Wtsi
(C57BL/6N-Col14a1tm1b(KOMP)Wtsi/Bay) 		impaired glucose tolerance J:211773
Col18a1tm1.1(KOMP)Vlcg/Col18a1tm1.1(KOMP)Vlcg
(B6N(Cg)-Col18a1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Colca2tm1b(NCOM)Mfgc/Colca2tm1b(NCOM)Mfgc
(C57BL/6N-Colca2tm1b(NCOM)Mfgc/Tcp) 		decreased fasting circulating glucose level J:211773
Commd9tm1b(KOMP)Wtsi/Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H) 		impaired glucose tolerance J:211773
Cops7atm1b(KOMP)Mbp/Cops7atm1b(KOMP)Mbp
(C57BL/6N-Cops7atm1b(KOMP)Mbp/Ucd) 		improved glucose tolerance J:211773
Coq6tm1b(EUCOMM)Hmgu/Coq6+
(C57BL/6N-Coq6tm1b(EUCOMM)Hmgu/Ics) 		increased fasting circulating glucose level J:211773
Coq8btm1b(EUCOMM)Hmgu/Coq8b+
(B6N(Cg)-Coq8btm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Corttm1Ldl/Corttm1Ldl
(involves: C57BL/6J) 		increased circulating glucose level J:179095
insulin resistance J:179095
Cox4i2tm1Hutt/Cox4i2tm1Hutt
(B6.129-Cox4i2tm1Hutt) 		improved glucose tolerance J:187640
Cox7ctm1b(KOMP)Mbp/Cox7c+
(B6N(Cg)-Cox7ctm1b(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Cpb1tm1.1(KOMP)Vlcg/Cpb1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cpb1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Cpdem1(IMPC)J/Cpd+
(C57BL/6NJ-Cpdem1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Cpefat/Cpefat
(involves: HRS/J) 		hyperglycemia J:10872
hypoglycemia J:13651
increased circulating insulin level J:13651, J:10872
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J) 		hyperglycemia J:10872
increased circulating insulin level J:24436, J:10872
Cpefat/Cpefat
Find1HRS/J/Find1HRS/J
(involves: C57BLKS/J * HRS/J) 		increased circulating glucose level J:100832
Cpefat/Cpefat
Find2C57BLKS/J/Find2C57BLKS/J
(involves: C57BLKS/J * HRS/J) 		decreased circulating insulin level J:100832
increased circulating glucose level J:100832
Cpetm1b(EUCOMM)Hmgu/Cpetm1b(EUCOMM)Hmgu
(C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6) 		abnormal glucose homeostasis J:95741
impaired glucose tolerance J:95741
increased circulating glucose level J:95741
increased circulating insulin level J:95741
insulin resistance J:95741
Cpt1atm1Pwo/Cpt1a+
(either: 129S6/SvEvTac-Cpt1atm1Pwo or (involves: 129S6/SvEvTac * C57BL/6NTac)) 		decreased circulating glucose level J:101934
Cpt1ctm1Dhwu/Cpt1ctm1Dhwu
(involves: 129 * C57BL/6J) 		enhanced gluconeogenesis J:148205
increased circulating glucose level J:148205
increased circulating insulin level J:148205
insulin resistance J:148205
Cpt1ctm1Mdln/Cpt1ctm1Mdln
(involves: C57BL/6) 		insulin resistance J:109455
Crattm1.1Pbrc/Crattm1.1Pbrc
Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * FVB) 		abnormal glucose homeostasis J:184778
impaired glucose tolerance J:184778
increased circulating glucose level J:184778
insulin resistance J:184778
Crbntm1Csp/Crbntm1Csp
(B6N.Cg-Crbntm1Csp) 		decreased circulating glucose level J:208570
decreased circulating insulin level J:208570
improved glucose tolerance J:208570
increased insulin sensitivity J:208570
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA) 		improved glucose tolerance J:75361
increased circulating insulin level J:75361
increased insulin sensitivity J:75361
Crebbptm1Few/Crebbp+
(Not Specified) 		abnormal glucose homeostasis J:91133
decreased circulating glucagon level J:91133
impaired glucose tolerance J:91133
increased circulating glucose level J:91133
increased circulating insulin level J:91133
increased liver glycogen level J:91133
insulin resistance J:91133
Crebbptm1Few/Crebbptm1Few
(Not Specified) 		abnormal glucose homeostasis J:91133
decreased circulating glucagon level J:91133
impaired glucose tolerance J:91133
increased circulating glucose level J:91133
increased circulating insulin level J:91133
increased liver glycogen level J:91133
Creg1em1Yal/Creg1em1Yal
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal glucose homeostasis J:263073
decreased glycogen level J:263073
impaired glucose tolerance J:263073
increased circulating insulin level J:263073
increased fasting circulating glucose level J:263073
insulin resistance J:263073
Creg2em1(IMPC)J/Creg2em1(IMPC)J
(C57BL/6NJ-Creg2em1(IMPC)J/Mmjax) 		decreased fasting circulating glucose level J:211773
Crhm1H/Crh+
(involves: C3H/HeH * C57BL/6J) 		abnormal glucose homeostasis J:208708
hyperglycemia J:208708
impaired glucose tolerance J:208708
increased circulating glucagon level J:208708
increased circulating insulin level J:208708
increased urine glucose level J:208708
insulin resistance J:208708
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J) 		abnormal circulating glucose level J:23082
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		abnormal circulating glucose level J:102987, J:105629
Crhr2tm1Klee/Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:83683
increased insulin sensitivity J:83683
Crispld2tm1Lex/Crispld2tm1Lex
(B6;129S5-Crispld2tm1Lex/Mmucd) 		improved glucose tolerance J:171883
Crls1tm1Geno/Crls1tm1Geno
Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6 * FVB/NJ) 		increased fasting circulating glucose level J:266083
insulin resistance J:266083
Crls1tm1Geno/Crls1tm1Geno
Tg(Ucp1-cre/ERT2)426Biat/0
(involves: C57BL/6N) 		insulin resistance J:266083
Crtc1Gt(XK522)Byg/Crtc1Gt(XK522)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		hyperglycemia J:142448
impaired glucose tolerance J:142448
increased circulating insulin level J:142448
Crtc2tm1.1Khk/Crtc2tm1.1Khk
(involves: C57BL/6 * C57BL/6J * FVB/N) 		abnormal glucose homeostasis J:151618
decreased glycogen level J:151618
Crtc2tm1Mmy/Crtc2tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased circulating insulin level J:157556
decreased fasting circulating glucose level J:157556
decreased hepatic glucose production J:157556
impaired gluconeogenesis J:157556
increased insulin sensitivity J:157556
Crtc3tm1Mmy/Crtc3tm1Mmy
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:167211
decreased circulating insulin level J:167211
increased insulin sensitivity J:167211
Crxem1(IMPC)Ccpcz/Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Cry1tm1Asn/Cry1tm1Asn
Cry2tm1Asn/Cry2tm1Asn
(involves: 129P2/OlaHsd * C57BL/6) 		impaired glucose tolerance J:128437
increased insulin sensitivity J:128437
Cstm1.1(KOMP)Wtsi/Cs+
(C57BL/6N-Cstm1.1(KOMP)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Csf2tm1Mlg/Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg) 		increased circulating glucose level J:145518
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		abnormal circulating glucose level J:142440
decreased circulating insulin level J:142440
enhanced gluconeogenesis J:142440
Csf2tm1Mlg/Csf2tm1Mlg
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Mlg Il3tm1Glli) 		hyperglycemia J:145518
impaired glucose tolerance J:145518
Csmd1tm1Lex/Csmd1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6NTac) 		improved glucose tolerance J:209700
Csnk1g2tm1b(EUCOMM)Wtsi/Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg) 		increased circulating glucose level J:211773
Csnk2a2em1(IMPC)Mbp/Csnk2a2em1(IMPC)Mbp
(C57BL/6N-Csnk2a2em1(IMPC)Mbp/MbpMmucd) 		decreased circulating glucose level J:211773
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ) 		impaired glucose tolerance J:184220
insulin resistance J:184220
Ctdspltm1.1(KOMP)Mbp/Ctdspltm1.1(KOMP)Mbp
(C57BL/6N-Ctdspltm1.1(KOMP)Mbp/Ucd) 		impaired glucose tolerance J:211773
Ctf1tm1Msd/Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd) 		hyperglycemia J:176727
increased circulating insulin level J:176727
insulin resistance J:176727
Cthrc1tm1Vli/Cthrc1tm1Vli
(129S6.Cg-Cthrc1tm1Vli) 		increased circulating glucose level J:192096
increased liver glycogen level J:192096
increased skeletal muscle glycogen level J:192096
insulin resistance J:192096
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde) 		hyperglycemia J:153355
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde) 		hyperglycemia J:153355
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr) 		hyperglycemia J:153355
Ctsmtm1(KOMP)Wtsi/Ctsmtm1(KOMP)Wtsi
(C57BL/6N-Ctsmtm1(KOMP)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Ctsstm1Eae/Ctss+
(NOD.D1-Ctsstm1Eae) 		hyperglycemia J:153355
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae) 		hyperglycemia J:153355
Cul4atm1b(EUCOMM)Hmgu/Cul4atm1b(EUCOMM)Hmgu
(C57BL/6N-Cul4atm1b(EUCOMM)Hmgu/Ccpcz) 		increased fasting circulating glucose level J:211773
Cxadrtm1Dvst/Cxadrtm1Dvst
(involves: 129X1/SvJ * C57BL/6) 		increased cardiac muscle glycogen level J:100174
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Cxcl14tm1Tha/Cxcl14tm1Tha
(involves: C57BL/6 * CBA) 		decreased circulating glucose level J:126841
decreased circulating insulin level J:126841
impaired glucose tolerance J:126841
improved glucose tolerance J:126841
increased insulin sensitivity J:126841
Cxcr1tm1a(EUCOMM)Wtsi/Cxcr1tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr1tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Cxcr3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6) 		increased circulating glucose level J:101679
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN) 		abnormal glucose homeostasis J:91486
decreased circulating insulin level J:91486
decreased insulin secretion J:91486
impaired glucose tolerance J:91486
increased circulating glucose level J:91486
increased insulin sensitivity J:91486
Cyb561tm1b(EUCOMM)Wtsi/Cyb561tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyb561tm1b(EUCOMM)Wtsi/H) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Cyb561a3tm2b(EUCOMM)Hmgu/Cyb561a3tm2b(EUCOMM)Hmgu
(C57BL/6N-Cyb561a3tm2b(EUCOMM)Hmgu/Ieg) 		increased fasting circulating glucose level J:211773
Cybbtm1.1Abk/Cybbtm1.1Abk
Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk) 		decreased circulating insulin level J:245699
decreased fasting circulating glucose level J:245699
Cybc1tm1a(KOMP)Wtsi/Cybc1tm1a(KOMP)Wtsi
(C57BL/6N-Cybc1tm1a(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Cyp4b1tm1b(KOMP)Wtsi/Cyp4b1tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4b1tm1b(KOMP)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Cyp4f16tm1b(KOMP)Wtsi/Cyp4f16tm1b(KOMP)Wtsi
(C57BL/6N-Cyp4f16tm1b(KOMP)Wtsi/H) 		increased fasting circulating glucose level J:211773
Cyp7b1tm1b(EUCOMM)Wtsi/Cyp7b1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp7b1tm1b(EUCOMM)Wtsi/Bay) 		impaired glucose tolerance J:211773
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased circulating insulin level J:147610
impaired glucose tolerance J:147610
Cyp17a1tm1b(EUCOMM)Wtsi/Cyp17a1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cyp17a1tm1b(EUCOMM)Wtsi/Nju) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H) 		increased fasting circulating glucose level J:211773
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac) 		abnormal glucose homeostasis J:65805
increased circulating insulin level J:65805
Cyp19a1tm1Toda/Cyp19a1tm1Toda
(involves: 129P2/OlaHsd * C57BL/6J) 		impaired glucose tolerance J:82070
increased circulating glucose level J:82070
insulin resistance J:82070
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Cyth3tm2a(KOMP)Wtsi/Cyth3tm2a(KOMP)Wtsi
(C57BL/6N-Cyth3tm2a(KOMP)Wtsi) 		decreased circulating glucose level J:272118
decreased liver glycogen level J:272118
insulin resistance J:272118
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
D630045J12Riktm1b(KOMP)Wtsi/D630045J12Riktm1b(KOMP)Wtsi
(C57BL/6N-D630045J12Riktm1b(KOMP)Wtsi/Tcp) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Daam2tm1a(KOMP)Wtsi/Daam2tm1a(KOMP)Wtsi
(C57BL/6N-Daam2tm1a(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
Dact3tm1b(KOMP)Wtsi/Dact3tm1b(KOMP)Wtsi
(C57BL/6N-Dact3tm1b(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Dbhtm1Rpa/Dbhtm1Rpa
(involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J) 		abnormal glucose homeostasis J:85772
decreased circulating glucagon level J:85772
decreased circulating glucose level J:85772
decreased glucagon secretion J:85772
increased circulating insulin level J:85772
insulin resistance J:85772
Dbil5tm1(KOMP)Wtsi/Dbil5tm1(KOMP)Wtsi
(C57BL/6N-Dbil5tm1(KOMP)Wtsi/Nju) 		increased circulating glucose level J:211773
Dbm1A/J/Dbm1A/J
Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc) 		increased circulating glucose level J:112869
increased circulating insulin level J:112869
Dbm2C57BL/6J/?
(involves: A/J * C57BL/6J) 		abnormal glucose homeostasis J:112869
increased circulating glucose level J:112869
Dbm3C57BL/6J/?
Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc) 		abnormal circulating glucose level J:112869
Dbm4C57BL/6J/?
Ins2Akita/Ins2+
(involves: A/J * C57BL/6J * C57BL/6NSlc) 		abnormal circulating glucose level J:112869
Dbnltm1b(KOMP)Wtsi/Dbnltm1b(KOMP)Wtsi
(C57BL/6N-Dbnltm1b(KOMP)Wtsi/Orl) 		increased circulating glucose level J:211773
Dbsq3C3H/HeJ/Dbsq3C3H/HeJ
Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS) 		increased circulating glucose level J:116038
Dbsq3C57BLKS/J/Dbsq3C3H/HeJ
Leprdb/Lepr+
(involves: C3H/HeJ * C57BLKS) 		increased circulating glucose level J:116038
Dbsty1NZO/HlLt/Dbsty1NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
increased circulating insulin level J:65256
Dbsty1NZO/HlLt/Dbsty1NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
increased circulating insulin level J:65256
Dbsty3NON/ShiLtJ/Dbsty3NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		insulin resistance J:65256
Dbsty3NZO/HlLt/Dbsty3NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		insulin resistance J:65256
Dbsty4NZO/HlLt/Dbsty4NON/ShiLtJ
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
Dbsty4NZO/HlLt/Dbsty4NZO/HlLt
(involves: NON/Lt * NZO/HlLt) 		hyperglycemia J:65256
Dbts1SM/J/?
(involves: LG/J * SM/J) 		impaired glucose tolerance J:94605
Dbts2SM/J/?
(involves: LG/J * SM/J) 		impaired glucose tolerance J:94605
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
improved glucose tolerance J:211773
Dcxtm1a(EUCOMM)Wtsi/Y
(C57BL/6N-Dcxtm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Ddi2tm1b(EUCOMM)Hmgu/Ddi2+
(C57BL/6N-Ddi2tm1b(EUCOMM)Hmgu/Ccpcz) 		impaired glucose tolerance J:211773
Ddit3tm2.1Dron/Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J) 		impaired glucose tolerance J:214136
insulin resistance J:214136
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng) 		increased circulating glucose level J:134371
Ddx58em1(IMPC)Mbp/Ddx58em1(IMPC)Mbp
(C57BL/6N-Ddx58em1(IMPC)Mbp/MbpMmucd) 		impaired glucose tolerance J:211773
Decr1tm1Jkh/Decr1tm1Jkh
(B6.129X1-Decr1tm1Jkh) 		decreased circulating glucose level J:151622
Defb20tm1b(EUCOMM)Hmgu/Defb20tm1b(EUCOMM)Hmgu
(C57BL/6N-Defb20tm1b(EUCOMM)Hmgu/J) 		decreased fasting circulating glucose level J:211773
Degs1Gt(OST368559)Lex/Degs1+
(involves: 129S5/SvEvBrd) 		increased insulin sensitivity J:203554
Del(7)Tyrc-3H/Del(7)Tyrc-3H
(involves: 101/H * C3H/HeH) 		decreased circulating glucose level J:5063
hypoglycemia J:5063
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff
(involves: 129S4/SvJae * C57BL/6) 		abnormal insulin secretion J:227939
improved glucose tolerance J:227939
increased circulating insulin level J:227939
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA) 		decreased circulating glucose level J:92536
increased circulating insulin level J:92536
increased insulin secretion J:92536
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj) 		decreased circulating glucose level J:199416
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
Depdc5tm1b(EUCOMM)Hmgu/Depdc5+
(C57BL/6N-Depdc5tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Deptortm1.1Mala/Deptortm1.1Mala
Speer6-ps1Tg(Alb-cre)21Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 x DBA) 		decreased fasting circulating glucose level J:275931
decreased liver glycogen level J:275931
increased insulin sensitivity J:275931
Derl2tm1.2Hpl/Derl2tm1.2Hpl
(involves: BALB/cJ) 		hypoglycemia J:170650
Dgat1tm1Far/Dgat1tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased circulating glucose level J:111346
improved glucose tolerance J:111346
increased insulin sensitivity J:61885
Dgat2tm1Far/Dgat2tm1Far
(involves: 129S4/SvJae * C57BL/6J) 		decreased liver glycogen level J:88742
hypoglycemia J:88742
Dgkdem1(IMPC)H/Dgkd+
(C57BL/6NTac-Dgkdem1(IMPC)H/H) 		decreased circulating glucose level J:211773
decreased fasting circulating glucose level J:211773
Dguoktm1.1Anka/Dguoktm1.1Anka
(involves: 129 * C57BL/6N) 		decreased circulating glucose level J:294620
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6) 		decreased circulating glucose level J:267178
improved glucose tolerance J:267178
increased circulating insulin level J:267178
increased insulin secretion J:267178
increased insulin sensitivity J:267178
increased liver glycogen level J:267178
Dhx30tm1.1(KOMP)Vlcg/Dhx30+
(C57BL/6N-Dhx30tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Dibg1129S6/SvEvTac/Dibg1129S6/SvEvTac
(involves: 129S6/SvEvTac * C57BL/6) 		hyperglycemia J:142949
Dis3tm1e.1(EUCOMM)Hmgu/Dis3+
(C57BL/6N-Dis3tm1e.1(EUCOMM)Hmgu/Ieg) 		impaired glucose tolerance J:211773
Diwg1C57BL/6/Diwg1C57BL/6
(involves: 129S6/SvEvTac * C57BL/6) 		hyperglycemia J:142949
Dkk1tm1.1Svo/Dkk1tm1.2Svo
Pax8tm1.1(cre)Mbu/Pax8+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		decreased urine glucose level J:173125
Dlgap4tm1b(KOMP)Wtsi/Dlgap4+
(C57BL/6N-Dlgap4tm1b(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Dlk1em1(IMPC)Wtsi/Dlk1em1(IMPC)Wtsi
(C57BL/6N-Dlk1em1(IMPC)Wtsi/WtsiIeg) 		decreased circulating glucose level J:211773
Dmbx1tm1Sse/Dmbx1tm1Sse
Lepob/Lepob
(involves: ICR) 		abnormal circulating glucose level J:125193
Dnaja4tm1b(KOMP)Wtsi/Dnaja4tm1b(KOMP)Wtsi
(C57BL/6N-Dnaja4tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
Dnajb3tm1.1(KOMP)Vlcg/Dnajb3tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb3tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Dnajb7tm1.1(KOMP)Vlcg/Dnajb7tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajb7tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(129P2/OlaHsd-Dnajb9Gt(KST256)Byg) 		decreased liver glycogen level J:226674
hypoglycemia J:226674
increased circulating glucagon level J:226674
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg) 		abnormal circulating glucose level J:226674
decreased circulating insulin level J:226674
decreased liver glycogen level J:226674
hypoglycemia J:226674
increased circulating glucagon level J:226674
Dnajc3tm8663Wcl/Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh) 		hyperglycemia J:98194
increased circulating insulin level J:98194
increased urine glucose level J:98194
Dnajc5gtm1.1(KOMP)Vlcg/Dnajc5g+
(C57BL/6N-Dnajc5gtm1.1(KOMP)Vlcg/J) 		increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Dnajc15Gt(RRN226)Byg/Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg) 		abnormal glycogen homeostasis J:204025
increased glycogen level J:204025
increased kidney glycogen level J:204025
increased liver glycogen level J:204025
Dnajc15tm1b(KOMP)Wtsi/Dnajc15tm1b(KOMP)Wtsi
(C57BL/6N-Dnajc15tm1b(KOMP)Wtsi/Bay) 		increased circulating glucose level J:211773
Dnajc19tm1a(EUCOMM)Hmgu/Dnajc19tm1a(EUCOMM)Hmgu
(C57BL/6N-Dnajc19tm1a(EUCOMM)Hmgu/H) 		increased circulating glucose level J:165965
Dnajc30tm1.1(KOMP)Vlcg/Dnajc30tm1.1(KOMP)Vlcg
(C57BL/6N-Dnajc30tm1.1(KOMP)Vlcg/J) 		improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Dnase1l2tm1.1(KOMP)Wtsi/Dnase1l2tm1.1(KOMP)Wtsi
(C57BL/6N-Dnase1l2tm1.1(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Dok1tm1Yyam/Dok1tm1Yyam
(B6.129S4-Dok1tm1Yyam) 		decreased circulating insulin level J:133566
improved glucose tolerance J:133566
increased insulin sensitivity J:133566
Dpm2tm1b(EUCOMM)Hmgu/Dpm2+
(C57BL/6N-Dpm2tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Dpp4tm1b(EUCOMM)Wtsi/Dpp4tm1b(EUCOMM)Wtsi
(C57BL/6N-Dpp4tm1b(EUCOMM)Wtsi/Ics) 		improved glucose tolerance J:211773
Dpp4tm1Lex/Dpp4tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J) 		improved glucose tolerance J:195941
Dpp4tm1Nwa/Dpp4tm1Nwa
(C57BL/6-Dpp4tm1Nwa) 		improved glucose tolerance J:62709
increased circulating glucagon level J:62709
increased circulating insulin level J:62709
increased insulin secretion J:62709
Dpp8em1(IMPC)J/Dpp8em1(IMPC)J
(C57BL/6NJ-Dpp8em1(IMPC)J/Mmjax) 		impaired glucose tolerance J:211773
Draxintm1Lex/Draxintm1Lex
(B6;129S5-Draxintm1Lex/Mmucd) 		decreased circulating insulin level J:171883
Dsg1cem1(IMPC)Mbp/Dsg1cem1(IMPC)Mbp
(C57BL/6N-Dsg1cem1(IMPC)Mbp/Ucd) 		increased circulating glucose level J:211773
Dspptm1.1(KOMP)Vlcg/Dspptm1.1(KOMP)Vlcg
(C57BL/6N-Dspptm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Dtnbp1tm1b(EUCOMM)Hmgu/Dtnbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dtnbp1tm1b(EUCOMM)Hmgu/Tcp) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
Dtx4em1(IMPC)Ccpcz/Dtx4+
(C57BL/6N-Dtx4em1(IMPC)Ccpcz/Ccpcz) 		impaired glucose tolerance J:211773
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd) 		increased fasting circulating glucose level J:211773
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
improved glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6) 		increased hepatic glucose production J:129718
Dusp3tm1b(KOMP)Wtsi/Dusp3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Dusp3tm1b(KOMP)Wtsi/Wtsi) 		increased circulating insulin level J:211773
Dusp4tm1a(EUCOMM)Wtsi/Dusp4tm1a(EUCOMM)Wtsi
(C57BL/6N-Dusp4tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:175295
Dusp26em1Jhxia/Dusp26em1Jhxia
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		decreased liver glycogen level J:279111
impaired glucose tolerance J:279111
increased circulating glucose level J:279111
increased fasting circulating glucose level J:279111
insulin resistance J:279111
Dync1h1tm1dIcs/Dync1h1+
(C57BL/6N-Dync1h1tm1dIcs/Ics) 		impaired glucose tolerance J:211773
Dynll1tm1(KOMP)Wtsi/Dynll1+
(C57BL/6N-Dynll1tm1(KOMP)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Dynlrb2tm1a(KOMP)Wtsi/Dynlrb2+
(C57BL/6N-Dynlrb2tm1a(KOMP)Wtsi/Wtsi) 		increased fasting circulating glucose level J:211773
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		abnormal circulating insulin level J:89720
decreased circulating glucose level J:89720
decreased circulating insulin level J:89720
decreased insulin secretion J:89720
impaired glucose tolerance J:89720
increased insulin sensitivity J:89720
Edn2tm1.1Nat/Edn2tm1.1Nat
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased circulating glucose level J:201436
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac) 		decreased circulating glucose level J:201436
Eef2kmttm1b(EUCOMM)Wtsi/Eef2kmttm1b(EUCOMM)Wtsi
(C57BL/6N-Eef2kmttm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
Efna5tm1b(EUCOMM)Wtsi/Efna5tm1b(EUCOMM)Wtsi
(C57BL/6N-Efna5tm1b(EUCOMM)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Efr3bem1(IMPC)Mbp/Efr3bem1(IMPC)Mbp
(C57BL/6N-Efr3bem1(IMPC)Mbp/Ucd) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Egfem1em1(IMPC)J/Egfem1em1(IMPC)J
(C57BL/6NJ-Egfem1em1(IMPC)J/J) 		decreased fasting circulating glucose level J:211773
impaired glucose tolerance J:211773
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara
Tg(Adipoq-cre)1Evdr/0
(involves: 129P2/OlaHsd * FVB/NJ) 		impaired glucose tolerance J:207678
increased circulating glucose level J:207678
increased circulating insulin level J:207678
insulin resistance J:207678
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac) 		abnormal insulin secretion J:76661
decreased circulating insulin level J:76661
hyperglycemia J:76661
impaired glucose tolerance J:76661
increased liver glycogen level J:76661
Eif2ak3tm1Dron/Eif2ak3+
(either: 129S6/SvEvTac-Eif2ak3tm1Dron or (involves: 129S6/SvEvTac * C57BL/6)) 		impaired glucose tolerance J:70005
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster) 		decreased circulating insulin level J:70005
hyperglycemia J:70005
Eif2b5tm1a(EUCOMM)Wtsi/Eif2b5+
(C57BL/6N-Eif2b5tm1a(EUCOMM)Wtsi/Ics) 		decreased circulating glucose level J:165965
Eif2s1tm1Rjk/Eif2s1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ) 		decreased circulating insulin level J:70004
decreased insulin secretion J:70004
hypoglycemia J:70004
Eif2s1tm1Rjk/Eif2s1tm1Rjk
Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd) 		hypoglycemia J:144954
Eif4ebp1tm1Nso/Eif4ebp1tm1Nso
(involves: 129S4/SvJae * BALB/c) 		hypoglycemia J:72217
Eif4g2tm1b(KOMP)Wtsi/Eif4g2+
(C57BL/6N-Eif4g2tm1b(KOMP)Wtsi/J) 		decreased circulating glucose level J:211773
impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Elapor1tm1b(EUCOMM)Hmgu/Elapor1+
(C57BL/6N-Elapor1tm1b(EUCOMM)Hmgu/Ics) 		increased circulating glucose level J:211773
Elk1tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Elk1tm1.1(KOMP)Vlcg/J) 		increased circulating insulin level J:211773
Elmo1tm1a(EUCOMM)Wtsi/Elmo1tm1a(EUCOMM)Wtsi
(C57BL/6N-Elmo1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H) 		decreased circulating glucose level J:165965
Elof1tm1.1(KOMP)Vlcg/Elof1+
(C57BL/6N-Elof1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Elovl6Gt(OST222498)Lex/Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating insulin level J:130031
improved glucose tolerance J:130031
increased insulin sensitivity J:130031
ElptC57BL/6J/ElptC57BL/6J
HypnC57BL/6/HypnC57BL/6
(involves: 129S6/SvEvTac * C57BL/6-Insrtm1Dac Irs1tm1Jos) 		increased circulating insulin level J:83539
Emc4tm1(KOMP)Wtsi/Emc4+
(C57BL/6N-Emc4tm1(KOMP)Wtsi/Nju) 		increased fasting circulating glucose level J:211773
Emc10Gt(OST181617)Lex/Emc10Gt(OST181617)Lex
(B6;129S5-Emc10Gt(OST181617)Lex/Mmucd) 		improved glucose tolerance J:171883
Emc10tm1b(EUCOMM)Wtsi/Emc10tm1b(EUCOMM)Wtsi
(C57BL/6N-Emc10tm1b(EUCOMM)Wtsi/H) 		decreased fasting circulating glucose level J:211773
Eml1em1(IMPC)Wtsi/Eml1em1(IMPC)Wtsi
(C57BL/6N-Eml1em1(IMPC)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Eml2tm1b(EUCOMM)Wtsi/Eml2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eml2tm1b(EUCOMM)Wtsi/Bay) 		decreased circulating glucose level J:211773
Enc1tm1a(EUCOMM)Wtsi/Enc1tm1a(EUCOMM)Wtsi
(C57BL/6N-Enc1tm1a(EUCOMM)Wtsi/Wtsi) 		decreased circulating glucose level J:211773
Enhotm1.1Butl/Enho+
(B6.Cg-Enhotm1.1Butl) 		impaired glucose tolerance J:225402
Enhotm1.1Butl/Enhotm1.1Butl
(B6.Cg-Enhotm1.1Butl) 		impaired glucose tolerance J:225402
increased circulating insulin level J:225402
increased fasting circulating glucose level J:225402
insulin resistance J:225402
Entpd1tm1a(EUCOMM)Wtsi/Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg) 		abnormal glucose homeostasis J:165965
Entpd5tm1Rre/Entpd5tm1Rre
(involves: 129S5/SvEvBrd * C57BL/6J) 		hypoglycemia J:163795
Epb41l4atm1b(KOMP)Mbp/Epb41l4atm1b(KOMP)Mbp
(C57BL/6N-Epb41l4atm1b(KOMP)Mbp/J) 		decreased circulating glucose level J:211773
Epg5em1(IMPC)H/Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H) 		decreased circulating glucose level J:211773
epi/?
(involves: CBA/J) 		decreased circulating glucose level J:5421
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J) 		hypoglycemia J:173769
improved glucose tolerance J:173769
increased cardiac muscle glycogen level J:173769
increased insulin sensitivity J:173769
Epm2aip1Gt(BA0314)Wtsi/Epm2aip1Gt(BA0314)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal gluconeogenesis J:204966
abnormal glucose homeostasis J:204966
abnormal glycogen homeostasis J:204966
decreased circulating glucose level J:204966
decreased liver glycogen level J:204966
improved glucose tolerance J:204966
Eprstm1.1Xen/Eprstm1.1Xen
(C57BL/6-Eprstm1.1Xen) 		impaired glucose tolerance J:244749
increased insulin sensitivity J:244749
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		decreased circulating glucose level J:117488
decreased circulating insulin level J:117488
Ercc5tm2b(EUCOMM)Hmgu/Ercc5+
(C57BL/6N-Ercc5tm2b(EUCOMM)Hmgu/Bay) 		increased fasting circulating glucose level J:211773
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Hvs/Xpatm1Hvs
(B6.129P2-Xpatm1Hvs Ercc6tm1Gvh) 		hypoglycemia J:122013
increased liver glycogen level J:122013
Ermp1tm1.1(KOMP)Vlcg/Ermp1tm1.1(KOMP)Vlcg
(C57BL/6N-Ermp1tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Ern1tm1Dron/Ern1+
(129S.129S6-Ern1tm1Dron) 		abnormal glucose homeostasis J:132805
Ero1aGt(XST171)Byg/Ero1aGt(XST171)Byg
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		impaired glucose tolerance J:158805
Ero1bGt(P077G11)Wrst/Ero1b+
(involves: 129S2/SvPas * C57BL/6) 		abnormal glucose homeostasis J:158805
decreased insulin secretion J:158805
impaired glucose tolerance J:158805
increased circulating glucose level J:158805
Ero1bGt(P077G11)Wrst/Ero1b+
Ins2Akita/Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc) 		decreased insulin secretion J:158805
impaired glucose tolerance J:158805
increased circulating glucose level J:158805
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		abnormal glucose homeostasis J:158805
decreased insulin secretion J:158805
impaired glucose tolerance J:158805
increased circulating glucose level J:158805
Esr1tm1.1Gust/Esr1tm1.1Gust
(B6.129X1-Esr1tm1.1Gust) 		increased circulating glucose level J:186230
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		insulin resistance J:66077
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd) 		impaired glucose tolerance J:151012
increased circulating glucose level J:151012
insulin resistance J:151012
Esr1tm1Ksk/Esr1tm1Ksk
(B6.129P2-Esr1tm1Ksk) 		impaired glucose tolerance J:65806
insulin resistance J:65806
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		insulin resistance J:66077
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd) 		decreased circulating glucose level J:151012
decreased insulin secretion J:151012
increased circulating glucose level J:151012
increased insulin sensitivity J:151012
Evi5tm1a(KOMP)Wtsi/Evi5tm1a(KOMP)Wtsi
(C57BL/6N-Evi5tm1a(KOMP)Wtsi/Wtsi) 		decreased fasting circulating glucose level J:211773
Evltm1b(KOMP)Wtsi/Evltm1b(KOMP)Wtsi
(C57BL/6N-Evltm1b(KOMP)Wtsi/H) 		increased fasting circulating glucose level J:211773
Exoc3tm2b(EUCOMM)Hmgu/Exoc3+
(C57BL/6N-Exoc3tm2b(EUCOMM)Hmgu/Wtsi) 		decreased fasting circulating glucose level J:211773
Exoc3l2em1(IMPC)J/Exoc3l2+
(C57BL/6N-Exoc3l2em1(IMPC)J/J) 		impaired glucose tolerance J:211773
Exosc3tm1.1(KOMP)Vlcg/Exosc3+
(C57BL/6N-Exosc3tm1.1(KOMP)Vlcg/Ucd) 		increased fasting circulating glucose level J:211773
Extl3tm1.1Okam/Extl3tm1Okam
Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR) 		decreased circulating insulin level J:148348
decreased insulin secretion J:148348
impaired glucose tolerance J:148348
Ezh1tm1b(EUCOMM)Wtsi/Ezh1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ezh1tm1b(EUCOMM)Wtsi/Nju) 		increased circulating glucose level J:211773
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6) 		abnormal glucose homeostasis J:130781
improved glucose tolerance J:130781
Fabp1tm1Bin/Fabp1tm1Bin
(involves: 129/Ola * C57BL/6) 		abnormal glucose homeostasis J:83875
Fabp1tm1Ddsn/Fabp1tm1Ddsn
(involves: 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:87278
decreased circulating insulin level J:87278
Fabp2tm1Mto/Fabp2tm1Mto
(B6.129S1-Fabp2tm1Mto) 		increased circulating insulin level J:64975
Fabp3Gt(XE705)Byg/Fabp3Gt(XE705)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:167535
decreased circulating glucose level J:167535
decreased liver glycogen level J:167535
Fabp3tm1Bin/Fabp3tm1Bin
(involves: 129P2/OlaHsd * BALB/c) 		hypoglycemia J:54614
Fabp3tm1Jshr/Fabp3+
(B6.129-Fabp3tm1Jshr) 		decreased circulating glucose level J:102858
increased insulin sensitivity J:102858
Fabp4tm1Brsp/Fabp4tm1Brsp
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal glucose homeostasis J:37027
decreased circulating insulin level J:57864
hypoglycemia J:37027
insulin resistance J:37027
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota) 		decreased circulating glucose level J:111878
increased insulin sensitivity J:111878
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
(involves: 129S7/SvEvBrd * C57BL/6J * SJL) 		decreased circulating glucose level J:217245
decreased glycogen level J:217245
decreased skeletal muscle glycogen level J:217245
Fabp4tm1Brsp/Fabp4tm1Brsp
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Fabp5tm1Hota Lepob) 		abnormal gluconeogenesis J:111878
abnormal glucose homeostasis J:111878
abnormal glycogen homeostasis J:111878
decreased circulating glucose level J:111878
decreased circulating insulin level J:111878
improved glucose tolerance J:111878
increased insulin sensitivity J:111878
Fabp4tm1Brsp/Fabp4tm1Brsp
Lepob/Lepob
(B6.Cg-Fabp4tm1Brsp Lepob) 		improved glucose tolerance J:111878
increased insulin sensitivity J:111878
Fabp5tm1Hota/Fabp5tm1Hota
(B6.Cg-Fabp5tm1Hota) 		decreased circulating glucose level J:81609
improved glucose tolerance J:81609
increased insulin sensitivity J:81609
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(involves: 129 * C57BL/6J * C57BL/10J * SJL) 		decreased circulating glucose level J:81609
improved glucose tolerance J:81609
increased circulating insulin level J:81609
increased insulin sensitivity J:81609
Fabp5tm1Hota/Fabp5tm1Hota
Lepob/Lepob
(B6.Cg-Fabp5tm1Hota Lepob) 		improved glucose tolerance J:111878
increased insulin sensitivity J:111878
Fads1tm1.1(KOMP)Vlcg/Fads1tm1.1(KOMP)Vlcg
(C57BL/6N-Fads1tm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Fahtm1Mgo/Fahtm1Mgo
(either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		hypoglycemia J:16046
Fam3btm1Bkht/Fam3btm1Bkht
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal glucose homeostasis J:167823
abnormal insulin clearance J:167823
decreased insulin secretion J:167823
impaired glucose tolerance J:167823
increased circulating insulin level J:167823
Fam13atm1e(KOMP)Wtsi/Fam13atm1e(KOMP)Wtsi
(C57BL/6N-Fam13atm1e(KOMP)Wtsi) 		impaired glucose tolerance J:258290
insulin resistance J:258290
Fam83dem1(IMPC)Ccpcz/Fam83dem1(IMPC)Ccpcz
(C57BL/6N-Fam83dem1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Fam126aem1(IMPC)Ccpcz/Fam126aem1(IMPC)Ccpcz
(C57BL/6N-Fam126aem1(IMPC)Ccpcz/Ccpcz) 		increased fasting circulating glucose level J:211773
Fam163atm2b(KOMP)Wtsi/Fam163atm2b(KOMP)Wtsi
(C57BL/6N-Fam163atm2b(KOMP)Wtsi/Wtsi) 		improved glucose tolerance J:211773
Fam184btm2b(EUCOMM)Wtsi/Fam184btm2b(EUCOMM)Wtsi
(C57BL/6N-Fam184btm2b(EUCOMM)Wtsi/Tcp) 		increased circulating glucose level J:211773
Fam186btm1b(KOMP)Mbp/Fam186btm1b(KOMP)Mbp
(C57BL/6N-Fam186btm1b(KOMP)Mbp/J) 		increased fasting circulating glucose level J:211773
Fam221aem1(IMPC)Ccpcz/Fam221aem1(IMPC)Ccpcz
(C57BL/6N-Fam221aem1(IMPC)Ccpcz/Ccpcz) 		increased circulating glucose level J:211773
Far2tm2b(KOMP)Wtsi/Far2tm2b(KOMP)Wtsi
(C57BL/6N-Far2tm2b(KOMP)Wtsi/J) 		increased fasting circulating glucose level J:211773
Farp1tm1b(EUCOMM)Hmgu/Farp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Farp1tm1b(EUCOMM)Hmgu/Ccpcz) 		increased fasting circulating glucose level J:211773
Farsatm2a(EUCOMM)Wtsi/Farsa+
(C57BL/6N-Farsatm2a(EUCOMM)Wtsi/Wtsi) 		impaired glucose tolerance J:211773
increased circulating insulin level J:211773
Fasntm1Sem/Fasntm1Sem
Speer6-ps1Tg(Alb-cre)21Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		decreased circulating glucose level J:127793
decreased circulating insulin level J:127793
increased circulating glucagon level J:127793
Fasntm1Sem/Fasntm1Sem
Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA) 		increased circulating glucose level J:127482
increased circulating insulin level J:127482
Fastktm1.1(KOMP)Vlcg/Fastktm1.1(KOMP)Vlcg
(C57BL/6N-Fastktm1.1(KOMP)Vlcg/Ucd) 		improved glucose tolerance J:211773
Fbf1tm1a(EUCOMM)Wtsi/Fbf1tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbf1tm1a(EUCOMM)Wtsi/Wtsi) 		increased circulating insulin level J:211773
increased fasting circulating glucose level J:211773
Fbgl1KK/Ta/Fbgl1KK/Ta
(involves: BALB/c * KK/Ta) 		hyperglycemia J:88209
Fbgl2KK/Ta/Fbgl2KK/Ta
(involves: BALB/c * KK/Ta) 		hyperglycemia J:88209
Fbp1m1Btlr/Fbp1m1Btlr
(C57BL/6J-Fbp1m1Btlr) 		hypoglycemia J:267693
Fbxl19tm1b(EUCOMM)Wtsi/Fbxl19+
(C57BL/6N-Fbxl19tm1b(EUCOMM)Wtsi/Nju) 		decreased circulating glucose level J:211773
Fbxo2tm1b(EUCOMM)Wtsi/Fbxo2tm1b(EUCOMM)Wtsi
(C57BL/6N-Fbxo2tm1b(EUCOMM)Wtsi/Nju) 		decreased fasting circulating glucose level J:211773
increased circulating glucose level J:211773
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju) 		decreased circulating glucose level J:211773
Fbxo30tm1b(KOMP)Wtsi/Fbxo30+
(C57BL/6N-Fbxo30tm1b(KOMP)Wtsi/J) 		improved glucose tolerance J:211773
Fcortm1Jnak/Fcortm1Jnak
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		impaired glucose tolerance J:184684
insulin resistance J:184684
Fem1btm1Jfma/Fem1btm1Jfma
(involves: 129X1/SvJ * C57BL/6) 		decreased insulin secretion J:100017
impaired glucose tolerance J:100017
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating insulin level J:141957
decreased circulating glucagon level J:141957
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified) 		abnormal gluconeogenesis J:129843
decreased circulating insulin level J:129843
decreased insulin secretion J:129843
improved glucose tolerance J:129843
increased insulin sensitivity J:129843
Ffar1tm1Lex/Ffar1tm1Lex
(involves: 129 * C57BL/6) 		decreased insulin secretion J:122092
Ffar1tm1Lex/Ffar1tm1Lex
(involves: C57BL/6 * C57BL/6J) 		abnormal glucagon secretion J:200805
increased circulating glucose level J:200805
Ffar2tm1Fmgb/Ffar2tm1Fmgb
(involves: 129S/SvEv) 		decreased circulating insulin level J:191508
impaired glucose tolerance J:191508
Ffar2tm1Soff/Ffar2tm1Soff
(B6.129-Ffar2tm1Soff) 		increased circulating insulin level J:227939
Ffar2tm2Soff/Ffar2tm2Soff
Ffar3tm2.1Soff/Ffar3tm2.1Soff
Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal insulin secretion J:227939
improved glucose tolerance J:227939
increased circulating insulin level J:227939
Ffar3tm1Fmgb/Ffar3tm1Fmgb
(involves: 129S/SvEv) 		impaired glucose tolerance J:191508
Ffar3tm1Soff/Ffar3tm1Soff
(B6.129-Ffar3tm1Soff) 		increased circulating insulin level J:227939
Ffar4tm1.1Mbj/Ffar4tm1.1Mbj
(involves: C57BL/6) 		abnormal insulin secretion J:211675
Ffar4tm1Gdds/Ffar4tm1Gdds
(involves: 129 * C57BL/6) 		impaired glucose tolerance J:182599
increased circulating glucose level J:182599
increased circulating insulin level J:182599
insulin resistance J:182599
Fgbtm1.1(KOMP)Vlcg/Fgbtm1.1(KOMP)Vlcg
(C57BL/6N-Fgbtm1.1(KOMP)Vlcg/Ucd) 		impaired glucose tolerance J:211773
Fgf21tm1.1Djm/Fgf21tm1.1Djm
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal gluconeogenesis J:150831
decreased circulating glucose level J:150831
hypoglycemia J:150831
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf) 		abnormal glucose homeostasis J:157309
impaired glucose tolerance J:157309
increased circulating glucose level J:157309
increased circulating insulin level J:157309
increased liver glycogen level J:157309
Fgf23tm1Blan/Fgf23tm1Blan
(involves: 129/Sv * C57BL/6) 		decreased circulating insulin level J:121006
hypoglycemia J:121006
improved glucose tolerance J:121006
Fgf23tm1Tyam/Fgf23tm1Tyam
(involves: C57BL/6 * CBA) 		hypoglycemia J:88172
Fgfr2tm2.3Dsn/Fgfr2+
(involves: 129 * C57BL/6 * FVB/N) 		hypoglycemia J:72517
Fgl1tm1Cuko/Fgl1tm1Cuko
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		abnormal gluconeogenesis J:199844
hyperglycemia J:199844
impaired glucose tolerance J:199844
Fglu2KK/?
(involves: C57BL/6J * KK-Ay) 		hyperglycemia J:81517
FgluKK/TaJcl/FgluKK/TaJcl
(involves: C57BL/6Jcl * KK.B6-Ay/Jcl) 		hyperglycemia J:51880
Fitm2tm1.1Dls/Fitm2tm1.1Dls
Tg(Fabp4-cre)1Rev/?
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal glucose homeostasis J:212437
increased circulating insulin level J:212437
insulin resistance J:212437
Fkbp1btm1.1Okam/Fkbp1btm1.1Okam
(ICR.129-Fkbp1btm1.1Okam) 		decreased insulin secretion J:136192
impaired glucose tolerance J:136192
Fmo5tm1Eshe/Fmo5tm1Eshe
(B6.129P2-Fmo5tm1Eshe) 		abnormal glucose homeostasis J:223365
decreased circulating glucose level J:223365
decreased fasting circulating glucose level J:223365
Fndc4tm1.1(KOMP)Vlcg/Fndc4tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc4tm1.1(KOMP)Vlcg/J) 		increased fasting circulating glucose level J:211773
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1) 		increased liver glycogen level J:187318
Fnip1m1Btlr/Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr) 		increased cardiac muscle glycogen level J:234285
Focadem1(IMPC)Bay/Focad+
(C57BL/6N-Focadem1(IMPC)Bay/BayMmucd) 		improved glucose tolerance J:211773
Fosl2tm2Wag/Fosl2tm2Wag
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		decreased circulating glucose level J:211215
impaired glucose tolerance J:211215
insulin resistance J:211215
Foxa1tm1Gsc/Foxa1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal circulating insulin level J:53312
decreased circulating glucagon level J:53312
hypoglycemia J:53312
Foxa1tm1Khk/Foxa1tm1Khk
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL) 		hyperglycemia J:143476
Foxa1tm1Stf/Foxa1tm1Stf
(Not Specified) 		abnormal glucose homeostasis J:57493
decreased circulating glucagon level J:57493
decreased circulating insulin level J:57493
decreased insulin secretion J:57493
hypoglycemia J:57493
impaired glucose tolerance J:57493
Foxa2tm1.1Stf/Foxa2tm1.1Stf
Tg(Nes-cre)1Kln/0
(B6.Cg-Foxa2tm1.1Stf Tg(Nes-cre)1Kln) 		decreased circulating glucose level J:155391
decreased circulating insulin level J:155391
improved glucose tolerance J:155391
increased insulin sensitivity J:155391
Foxa2tm1Dnl/Foxa2+
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal glucose homeostasis J:95662
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		abnormal insulin secretion J:70409
decreased circulating glucagon level J:70409
hypoglycemia J:70409
increased circulating insulin level J:70409
increased glycogen level J:70409
Foxa2tm1Khk/Foxa2tm1Khk
Tg(Foxa3-cre)1Khk/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		decreased circulating glucagon level J:96332
hypoglycemia J:96332
Foxa3tm1Khk/Foxa3tm1Khk
(B6.129P2-Foxa3tm1Khk) 		decreased fasting circulating glucose level J:72595
decreased hepatic glucose production J:72595
increased insulin sensitivity J:216477
Foxi2tm1.1(KOMP)Vlcg/Foxi2tm1.1(KOMP)Vlcg
(C57BL/6N-Foxi2tm1.1(KOMP)Vlcg/J) 		decreased circulating glucose level J:211773
Foxm1tm1Rhc/Foxm1tm1Rhc
Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal glucose homeostasis J:111026
abnormal insulin secretion J:111026
impaired glucose tolerance J:111026
Foxo1tm1Rdp/Foxo1tm1Rdp
Foxo3tm1Rdp/Foxo3tm1Rdp
Foxo4tm1Rdp/Foxo4tm1Rdp
Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J) 		abnormal glucose homeostasis J:215526
decreased circulating insulin level J:215526
decreased insulin secretion J:215526
hyperglycemia J:215526
impaired glucose tolerance J:215526
Foxo1tm1Rdp/Foxo1tm1Rdp
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA * FVB) 		improved glucose tolerance J:137845
Foxo1tm1Whb/Foxo1+
(Not Specified) 		decreased liver glycogen level J:79560
Foxo1tm1Whb/Foxo1+
Insrtm1Dac/Insrtm1Dac
(involves: 129S4/SvJae * C57BL/6) 		decreased circulating glucose level J:79560
Foxo1tm1Whb/Foxo1+
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		decreased circulating glucose level J:109010
increased circulating insulin level J:109010
Foxo1tm2.1Dac/Foxo1tm2.1Dac
(Not Specified) 		abnormal gluconeogenesis J:179687
abnormal glucose homeostasis J:179687
increased circulating glucose level J:179687
increased circulating insulin level J:179687
insulin resistance J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
Insrtm1Dac/Insr+
(involves: 129S4/SvJae * C57BL/6) 		increased circulating insulin level J:179687
insulin resistance J:179687
Foxo1tm2.1Dac/Foxo1tm2.1Dac
Leprdb/Leprdb
(B6.Cg-Foxo1tm2.1Dac Leprdb) 		impaired glucose tolerance J:179687
increased circulating insulin level J:179687
Foxo3tm1.1(KOMP)Vlcg/Foxo3tm1.1(KOMP)Vlcg
(C57BL/6N-Foxo3tm1.1(KOMP)Vlcg/J) 		impaired glucose tolerance J:211773
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		impaired glucose tolerance J:118179, J:84269
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg) 		abnormal gluconeogenesis J:236585
decreased circulating glucose level J:236585
decreased circulating insulin level J:236585
decreased fasting circulating glucose level J:236585
improved glucose tolerance J:236585
increased insulin sensitivity J:236585
FpliC57BL/6J/?
(involves: C57BL/6J * KK-Ay) 		increased circulating insulin level J:81517
Fshrtm1(KOMP)Vlcg/Fshrtm1(KOMP)Vlcg
(C57BL/6N-Fshrtm1(KOMP)Vlcg/Nju) 		increased fasting circulating glucose level J:211773
Fstl1tm1.1Ning/Fstl1tm1.1Ning
(involves: 129S4/SvJae * C57BL/6J * FVB/N) 		increased glycogen level J:171347
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
Fstl3tm1Alsc/Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		decreased liver glycogen level J:119526
improved glucose tolerance J:119526
increased circulating insulin level J:119526
increased insulin sensitivity J:119526
FtoI367F/FtoI367F
(involves: C3H/HeH * C57BL/6J) 		decreased circulating insulin level J:152163
increased circulating glucagon level J:152163
increased circulating glucose level J:152163
Ftotm1.2Rdc/Ftotm1.2Rdc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL) 		improved glucose tolerance J:194922
Ftotm1Urt/Ftotm1Urt
Lepob/Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		insulin resistance J:219118
Fzd3tm1b(EUCOMM)Hmgu/Fzd3+
(C57BL/6N-Fzd3tm1b(EUCOMM)Hmgu/H) 		impaired glucose tolerance J:211773
G0s2tm1(KOMP)Vlcg/G0s2tm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		decreased circulating insulin level J:209000
improved glucose tolerance J:209000
increased insulin sensitivity J:209000
G0s2tm1Jgte/G0s2tm1Jgte
(involves: 129S7/SvEvBrd) 		improved glucose tolerance J:219653
increased insulin sensitivity J:219653
G6pc2tm1Lex/G6pc2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased circulating glucose level J:141593
G6pc3tm1Rmob/G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased circulating glucagon level J:117664
G6pctm1.1Ics/G6pctm1.1Ics
Albtm1(cre/ERT2)Mtz/Alb+
(involves: 129S2/SvPas * C57BL/6J) 		increased liver glycogen level J:195257
G6pctm1.1Ics/G6pctm1.1Ics
Tg(Kap-icre)29066/2Sig/0
(involves: 129S2/SvPas * C57BL/6J * SJL) 		increased kidney glycogen level J:238264
G6pctm1Jyc/G6pctm1Jyc
(involves: 129S4/SvJae) 		abnormal glucose homeostasis J:33212
decreased circulating glucose level J:33212
increased kidney glycogen level J:33212
increased liver glycogen level J:33212
G6pctm2.2Jyc/G6pctm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N) 		hypoglycemia J:155990
increased kidney glycogen level J:155990
increased liver glycogen level J:155990
Gaatm1.1Rabn/Gaatm1.1Rabn
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased brain glycogen level J:76435
increased cardiac muscle glycogen level J:76435, J:48839
increased skeletal muscle glycogen level J:76435, J:48839
Gaatm1Rabn/Gaatm1Rabn
(involves: 129X1/SvJ * C57BL/6) 		increased brain glycogen level J:76435
increased cardiac muscle glycogen level J:235790, J:76435, J:48839
increased liver glycogen level J:235790
increased skeletal muscle glycogen level J:235790, J:48839, J:73924
Gaatm1Rabn/Gaatm1Rabn
Stbd1tm1Bsn/Stbd1tm1Bsn
(involves: 129X1/SvJ * C57BL/6) 		increased cardiac muscle glycogen level J:235790
increased liver glycogen level J:235790
increased skeletal muscle glycogen level J:235790
Gaatm1Rabn/Gaatm1Rabn
Tg(CMV-GAA*P545L)#Kjv/0
(involves: 129X1/SvJ * C57BL/6) 		increased glycogen level J:219022
increased skeletal muscle glycogen level J:219022
Gaatm1Vdp/Gaatm1Vdp
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB)) 		abnormal glycogen homeostasis J:45386
Gaatm2Rabn/Gaatm2Rabn
(involves: 129X1/SvJ * C57BL/6) 		increased brain glycogen level J:76435
increased cardiac muscle glycogen level J:76435
increased skeletal muscle glycogen level J:76435
Gab1tm1Gsf/Gab1tm1Gsf
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal glucose homeostasis J:98318
decreased circulating glucose level J:98318
decreased circulating insulin level J:98318
decreased glycogen level J:98318
improved glucose tolerance J:98318
increased insulin sensitivity J:98318
Gad2tm1b(EUCOMM)Wtsi/Gad2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gad2tm1b(EUCOMM)Wtsi/Ieg) 		impaired glucose tolerance J:211773
increased fasting circulating glucose level J:211773
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya) 		increased circulating glucose level J:88785
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong
Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		decreased insulin secretion J:220742
impaired glucose tolerance J:220742
Gaktm2Legr/Gaktm2Legr
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		decreased liver glycogen level J:180119
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn) 		abnormal circulating insulin level J:105628
decreased insulin secretion J:105628
Gasttm1(INS)Ez/Gast+
(involves: 129S4/SvJae * C57BL/6) 		abnormal insulin secretion J:99270
improved glucose tolerance J:99270
increased circulating insulin level J:99270
Gasttm1(INS)Ez/Gast+
Ins2Akita/Ins2+
(involves: 129S4/SvJae * C57BL/6NSlc) 		abnormal circulating glucose level J:99270
Gatmtm1.1Isb/Gatmtm1.1Isb
(B6.129-Gatmtm1.1Isb) 		abnormal gluconeogenesis J:191142
abnormal glucose homeostasis J:191142
decreased circulating glucose level J:191142
decreased circulating insulin level J:191142
improved glucose tolerance J:191142
GaucKK/?
(involves: C57BL/6J * KK-Ay) 		impaired glucose tolerance J:81517
Gbe1m1Yty/Gbe1m1Yty
(C3HeB/FeJ-Gbe1m1Yty) 		decreased cardiac muscle glycogen level J:167233
Gbe1tm1.1Hoa/Gbe1tm1.1Hoa
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:176889
decreased liver glycogen level J:176889
decreased skeletal muscle glycogen level J:176889
Gbe1tm1Hoa/Gbe1tm1Hoa
(involves: 129S7/SvEvBrd) 		abnormal glucose tolerance J:176889
decreased circulating glucose level J:176889
decreased glycogen catabolism rate J:176889
increased liver glycogen level J:176889
increased skeletal muscle glycogen level J:176889
Gbe1tm2.1Hoa/Gbe1tm2.1Hoa
(involves: 129S7/SvEvBrd) 		abnormal glucose homeostasis J:226481
abnormal muscle glycogen level J:226481
decreased fasting circulating glucose level J:226481
increased brain glycogen level J:226481
increased glycogen level J:226481
increased liver glycogen level J:226481
Gbe1tm2Hoa/Gbe1tm2Hoa
(involves: 129S7/SvEvBrd) 		abnormal muscle glycogen level J:226481
increased brain glycogen level J:226481
increased glycogen level J:226481
increased liver glycogen level J:226481
Gbp2tm1b(KOMP)Wtsi/Gbp2tm1b(KOMP)Wtsi
(C57BL/6N-Gbp2tm1b(KOMP)Wtsi/Ieg) 		increased fasting circulating glucose level J:211773
Gctm1.1(KOMP)Vlcg/Gctm1.1(KOMP)Vlcg
(C57BL/6N-Gctm1.1(KOMP)Vlcg/Ucd) 		decreased circulating glucose level J:211773
Gcgtm1Yhys/Gcgtm1Yhys
(B6.129S6-Gcgtm1Yhys) 		decreased circulating insulin level J:154694
improved glucose tolerance J:154694
increased circulating glucose level J:154694
increased insulin sensitivity J:154694
Gcgrem1Tshu/Gcgrem1Tshu
(involves: C57BL/6J) 		decreased fasting circulating glucose level J:279017
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc) 		decreased fasting circulating glucose level J:300368
improved glucose tolerance J:300368
increased circulating glucagon level J:300368
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp) 		decreased circulating glucose level J:176507
decreased circulating insulin level J:176507
increased circulating glucagon level J:176507, J:73926
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL) 		decreased circulating glucose level J:81772
decreased circulating insulin level J:251829
hypoglycemia J:251829, J:81772
improved glucose tolerance J:81772
increased circulating glucagon level J:251829, J:81772
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL) 		decreased circulating insulin level J:208604
improved glucose tolerance J:208604
increased circulating glucagon level J:208604
increased glucagon secretion J:208604
increased insulin sensitivity J:208604
Gcgrtm1Mjch/Gcgrtm1Mjch
Slc38a5tm1(KOMP)Vlcg/Slc38a5tm1(KOMP)Vlcg
(involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL) 		decreased circulating insulin level J:251829
hypoglycemia J:251829
increased circulating glucagon level J:251829
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		abnormal glucose homeostasis J:208604
decreased circulating glucose level J:208604
decreased circulating insulin level J:208604
hypoglycemia J:208604
improved glucose tolerance J:208604
increased circulating glucagon level J:208604
increased insulin sensitivity J:208604
Gckem1(IMPC)H/Gck+
(C57BL/6NTac-Gckem1(IMPC)H/H) 		impaired glucose tolerance J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
GckGena348/Gck+
(involves: BALB/c * C3H/He) 		hyperglycemia J:82809, J:79719, J:90389
impaired glucose tolerance J:90389
GckGena348/GckGena348
(involves: BALB/c * C3H/He) 		hyperglycemia J:90389
impaired glucose tolerance J:90389
GckGls006/Gck+
(C3HeB/FeJ-GckGls006) 		decreased circulating insulin level J:189544
decreased insulin secretion J:189544
hyperglycemia J:189544
impaired glucose tolerance J:189544
increased circulating glucose level J:189544
GckGls006/GckGls006
(C3HeB/FeJ-GckGls006) 		hyperglycemia J:137483, J:189544
increased circulating glucose level J:189544